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In the 1940s, antibiotics were firstly applied as clinical medicine in treating 
infections.  Initially, the efficiency of antibiotics in killing pathogenic bacteria has led 
many to believe that antibiotics would be potent to eliminate all infectious diseases 
from human beings.  Disappointedly, the successful use of the therapeutic antibiotics 
has been compromised by the emergence and rapid dissemination of resistant 
pathogens, especially multi-drug resistant microorganisms.  The recent development 
of antibiotic resistance in pathogens is believed to be a result of anthropogenic 
activities, the massive production and application of antibiotics in the disease 
treatment and growth promotion.  However, the lack of knowledge on the evolution of 
antibiotic resistance genes and environmental roles of antibiotics has hampered efforts 
to prevent and control the proliferation of antibiotic resistance.  This drives the need 
to investigate antibiotic influence on wastewater treatment plants (WWTPs), which 
are the main collection pools of anthropogenic discharges of antibiotics and antibiotic 
resistance genes.  The influences of antibiotics on micro-ecosystem of WWTPs 
include ecological function disturbance, resistance selection and phylogenetic 
structure alteration, which are the focuses of this study.  
This dissertation firstly demonstrated the effects of antibiotic erythromycin 
(ERY, 100 µg/L) and its derivative ERY-H2O (50 µg/L) on the disturbance of 
ecological functions, including carbon, nitrogen (N), and phosphorus (P) removal in 
sequencing batch reactors (SBRs) (chapter 3).  The findings in this study show that 
the effects of ERY or ERY-H2O on the removal of carbon, N, and P were negligible 
when compared with the control reactor.  However, ERY and ERY-H2O had 
pronounced effects on the community composition of bacteria associated with N and 
P removal, leading to a decrease in diversity and a change in abundance.  Therefore, 
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the presence of ERY or ERY-H2O (at µg/L levels) shifted the microbial community 
and selected antibiotic resistant bacteria, which may account for the negligible 
influence of the antibiotic ERY or its derivative ERY-H2O on carbon, N, and P 
removal in the SBRs. 
This thesis further identified the causal correlation of trace ERY (100 µg/L) or 
ERY-H2O (50 µg/L) with antibiotic resistance proliferation (chapter 4).  
Erythromycin resistance genes were screened on microbial consortia of SBRs after 
one year acclimation to ERY (100 µg/L) and ERY-H2O (50 µg/L).  Results revealed 
that the effects of ERY and ERY-H2O on the proliferation of antibiotic resistance 
genes were limited to esterase gene ereA.  The above consortia of SBRs were also 
applied to evaluate their capability to esterify ERY through ereA gene.  Results 
showed that ERY was bio-transformed into six products by microbes acclimated to 
ERY (100 µg/L).  However, ERY could not be bio-transformed by those microbes 
acclimated to ERY-H2O (50 µg/L), which may be due to the less amounts of 
proliferated ereA gene.  Biodegradation of ERY required the exogenous carbon 
source (e.g., glucose) and nutrients (e.g., nitrogen, phosphorous) for assimilation.  
However, overdosed ammonium–N (>40 mg/L) inhibited degradation of ERY.  
Zoogloea, a type of biofilm-forming bacteria, became predominant in the process of 
ERY esterification, suggesting that the input of ERY can induce biofilm resistance to 
antibiotics.  This study highlighted that lower µg/L level of ERY or ERY-H2O in the 
environment is able to encourage the expansion of resistance genes in microbes.  
In chapter 5, the  microbial consortia in the SBRs fed with ERY (100 µg/l) or 
ERY-H2O (50 µg/l) were analyzed in terms of phylogenetic structure alteration based 
on 16S rRNA genes, including terminal restriction fragment length polymorphism (T-
RFLP), denaturing gradient gel electrophoresis (DGGE), and microarrays 
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(PhyloChip).  Results revealed that both ERY and ERY-H2O markedly altered the 
composition and structure of the microbial communities in similar inhibitory and 
selective spectrum when comparing with the control SBR.  The Gram-positive 
Actinobacteria and Gram-negative Proteobacteria were inhibited in terms of both 
diversity and abundance.  The abundance-enriched bacteria belonged to the TM7 
phylum and the β-Proteobacteria subphylum (within the genera of Azonexus, 
Dechloromonas, Thauera, and zoogloea under the Rhodocyclaceae family, and the 
Nitrosomonas genus).  The enriched zoogloea are capable of forming biofilm to resist 
antibiotics, and other enriched Rhodocyclaceae (Azonexus,  Thauera, and 
Dechloromonas) and the Nitrosomonas are able to reduce nitrate and oxidize 
ammonium in order to eliminate these toxic nitrogenous substances accumulated in 
the biofilm.  This is known as biofilm resistance to antibiotics.  With phylogenetic 
analysis on uncultured samples, the results of this study suggested that low levels of 
ERY or ERY-H2O can alter microbial communities via the inhibition of sensitive 
bacteria and the enrichment of biofilm antibiotic resistant bacteria. 
In summary, low dose of antibiotics and their derivatives play significant roles 
in selecting resistant bacteria and proliferating resistance genes among microbes.  
With the increasing usage of recycled wastewater (e.g., as potable and non-potable 
water sources), sub-inhibitory concentrations of antibiotics in WWTPs might pose 
potential risks to human health. 
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1.1    Background and problem statement 
“Emerging contaminants are defined as compounds that are not currently 
covered by existing regulations of water quality, that have not been previously 
studied, and that are thought to be a possible threat to environmental health and 
safety” (Ferrer and Thurman, 2003).  Based on this broad definition, emerging 
contaminants consist of diverse compounds, such as human and veterinary 
pharmaceuticals, personal care products, surfactants and surfactant residues, pesticide 
degradates, plasticizers, and various industrial additives (Ferrer and Thurman, 2003).  
It is only in recent years that the negative impacts of these contaminants on the 
environment have started to raise concern among the public, although most of these 
pollutants have been existent in the environment for decades.  Thus, the concerns for 
these contaminants are emerging (Daughton, 2004).  Nevertheless, the exact effects of 
many pollutants on humans and aquatic ecosystems are not well understood.    
Antibiotics, one kind of emerging contaminants due to their potential to induce 
antibiotic resistant bacteria and transfer antibiotic resistance genes, have attracted 
growing attentions from researchers and the public over the past 20 years.  Antibiotics 
initially originated from natural templates, which could be produced by particular 
species of bacteria or fungi as a competition mechanism to ensure their own survival 
(e.g., to gain a larger share of environmental substrate supplies by killing or inhibiting 
competitors) (Hancock, 2005).  These natural antibiotics were firstly introduced into 
the clinical practice in the 1940s, and were proved efficient in dealing with diseases 
caused by pathogenic bacteria in human beings (Aminov, 2009).  However, the 
emergence of multi-drug resistant pathogens has resulted in serious therapeutic 
difficulties in controlling infections using the natural antibiotics since the 1960s 
(Aminov, 2009).  In order to cope with such super pathogens, tremendous amount of 
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money and time have been spent on modifying natural antibiotics to avoid resistance 
since the 1970s.  Despite of such efforts, the exploitation of artificial antibiotics is still 
lagging behind the mutation of those super bugs.  Therefore, efforts have shifted 
towards the control of usage and discharge of antibiotics in recent 20 years, because 
trace levels of antibiotics (e.g., from ng/L to µg/L levels) discharged into the 
environment by anthropogenic activities are suspected to select resistant bacteria and 
enhance resistance gene transfer in the environment.  However, knowledge on 
correlation of antibiotic resistance development with antibiotics at environmental 
concentrations is still limited (Daughton and Ternes, 1999; Kummerer, 2009b).   
Previously, it was assumed that antibiotics at lower environmental 
concentrations (from ng/L to µg/L levels) may play similar antibiotic roles, and 
develop similar resistance mechanisms in the same patterns as those at higher 
therapeutic concentrations (mg/L levels).  However, it has been recently recognized 
that sub-inhibitory antibiotics are suspected to play signaling and regulatory roles in 
micro-ecosystems, while higher to lethal concentrations of antibiotics used in 
therapeutic practices act as a stress to inhibit or kill microorganisms (Davies et al., 
2006; Linares et al., 2006; Martinez, 2008; Yim et al., 2006).  The variability of 
antibiotic resistance genes in environmental bacteria are identified as a evolutionary 
result of ancient mutation for more than two billion years, but the rapid dissemination 
of resistance genes during the past 70 years are mainly due to the horizontal gene 
transfer among both taxonomically close and distant bacteria (Aminov, 2009).  
Previously, the mutation and gene transfer were considered as two parallel resistance 
gene development modes (Lipsitch and Samore, 2002).  All the new understandings 
about roles of antibiotics and antibiotic resistance in nature have changed the current 
paradigm and driven us to clarify the relationship between antibiotic resistance and 
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sub-inhibitory antibiotics and to elucidate how resistance is regulated by low dose 
antibiotics in the environment. 
The current occurrence of antibiotics in the environment is mainly from 
anthropogenic activities, such as wastewater discharge, manure disposal and 
aquaculture application (Kummerer, 2009a).  Compared to the latter two, wastewater 
has a more direct influence on human beings due to the wide usage of recycled 
wastewater (e.g., as potable and non-potable water sources), which may spread many 
underused antibiotics to every spots of the world and may transfer antibiotic 
resistance genes to clinical pathogens (Ding and He, 2010; Le-Minh et al., 2010).  
However, studies about effects of antibiotics on wastewater are fewer compared to 
studies on manual-applied soil and antibiotics-contaminated aquaculture sediments.  
This is due to that: (1) relatively lower concentrations of antibiotics in wastewater 
may lead to less pronounced effects, (2) antibiotic resistant bacteria and resistance 
genes brought by wastewater may mask the antibiotic own effects on resistance 
development, and (3) mobile and lower density of microbes in wastewater may result 
in difficulty in detecting and comparing microbial community structures (Ding and 
He, 2010).   
Fortunately, wastewater is finally collected in wastewater treatment plants 
(WWTPs), the compartments with higher diversity and density of microorganisms, in 
which the occurrence and transfer of new combination of resistance genes are found 
to be much more frequent (Murray, 1997).  This has inspired researchers to 
investigate the occurrence of antibiotics and antibiotic resistance in WWTPs and 
downstream natural waters in the past decade (Le-Minh et al., 2010).  However, 
investigations on causal relationship of antibiotics with intensification of resistance 
genes became increasingly difficult, because the exotic antibiotic resistance brought 
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by wastewater may mask the effects of antibiotics on resistance development, and 
there is a lack of reference WWTPs free from the input of resistance bacteria and 
genes.  In addition, almost all current WWTPs have been contaminated with 
antibiotics.  Without antibiotic-uncontaminated WWTPs as negative control, less 
pronounced influence of antibiotics on WWTPs performance, such as carbon, 
nitrogen and phosphorus removal, are difficult to be discovered due to lower 
concentrations of antibiotics.  Moreover, since the majority of microorganisms in the 
environment (e.g. WWTPs) are not cultivated yet (Amann et al., 1995), high 
throughput uncultured-methods are necessary to detect, characterize and quantify both 
dominant and less dominant but important microbes in WWTPs.  Otherwise, effects 
of low dose antibiotics on microbial community shift are unlikely to be discovered.  
Among many kinds of antibiotics in WWTPs, erythromycin (ERY) and its 
derivative ERY-H2O are among the antibiotics with the lowest removal rate in 
WWTPs (Rosal et al., 2010), and they are also among the most frequently detected 
antibiotics in surface water, ground water, and untreated drinking water sources 
(Focazio et al., 2008).  Since ERY-H2O is structurally similar to ERY, they both may 
have signaling functions as other sub-inhibitory antibiotics in the environment. 
Examples of the signaling functions include to stimulate horizontal gene transfer in 
microbial ecosystems, to select resistant bacteria among functionally redundant 
microorganisms, and to regulate microbial community components through cross-
species talk (e.g., quorum-sensing (QS)).  For instance, sub-inhibitory concentrations 
of ERY has been reported to activate the expression of specific gene encoding for 
polysaccharide intercellular adhesion in Staphylococcus (Rachid et al., 2000).  
Therefore, the influence of ERY and ERY-H2O on the ecological function in WWTPs 




1.2    Objectives and aims 
In this study, we aim to investigate the effects of low concentrations of ERY 
(100 µg/L) and its derivative ERY-H2O (50 µg/L) on ecological function disturbance 
(carbon, nitrogen and phosphorus removal), resistance selection and microbial 
community shift in lab-scale sequencing batch reactors (SBRs, the simulation of 
WWTPs).   
Three SBRs (4L) were started up and operated over one year in exactly the 
same conditions, including seeding sludge, feeding synthetic wastewater (theoretical 
chemical oxygen demand (COD), NH4+–N, and PO43-–P of 600, 60, and 15 mg/L, 
respectively), and an 8-hour operating batch mode, but differed only in terms of 
antibiotics spiked, ERY-H2O of 50 µg/L (R1), ERY of 100 µg/L (R2), and no 
antibiotics (R3), respectively.  Noteworthy, an 8-month pretreatment with the 
synthetic wastewater was applied on the seeding sludge in a mother reactor (MR) 
before being inoculated to the three SBRs.  The pretreatment was expected to 
minimize residue antibiotics and antibiotic resistance, since the synthetic wastewater 
was absent of antibiotics, antibiotic resistance genes and resistant bacteria.  
Accordingly, the synthetic wastewater-feeding SBRs were free from input of exotic 
antibiotic resistance, and were able to demonstrate causal relationship of antibiotics 
with development of antibiotic resistance.  In addition, R3 is used as an antibiotic-
uncontaminated negative control reactor for comparison with another two reactors in 
terms of reactor performance and microbial community components. The specific 
scopes of studies are: 
(1) To assess the influence of ERY or ERY-H2O at low concentrations (µg/L) 
on the carbon, nitrogen, and phosphorus removal in SBRs.  The inhibitory effects on 
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carbon and nutrients removal are evaluated by a long-term operation of the three 
SBRs.  The nitrogen and phosphorus removal related microorganisms in the three 
steady state SBRs are analyzed by employing high-density phylogenic 16S rRNA 
gene microarrays (PhyloChip) containing 1,440 distinguishable prokaryotic 
operational taxonomic units (OTUs), and the community shifts in R1 (ERY-H2O) and 
R2 (ERY) are compared with that in R3 (control).  To verify whether the PhyloChip-
observed nitrifying bacteria shifts are correlated with their resistance to ERY, short-
term running batch experiments are conducted to study higher concentrations (100, 
400, and 800 µg/L) of ERY’s inhibition on nitrifying bacteria present in the biomass 
of the three steady state SBRs.  The study will shed light on the influence of ERY and 
ERY-H2O at the µg/l levels on the microbial ecological functions of treatment 
systems (e.g., the complex WWTPs as one of the most highly antibiotics-exposed 
environments). 
(2) To identify the development of resistance genes and to investigate the 
biodegradation of ERY with microbial consortia acclimated to ERY (100 µg/L) or 
ERY-H2O (50 µg/L) after long-term running with synthetic wastewater free from 
resistant bacteria and resistance genes input.  Findings of this study will provide 
significant information on the inadequate data on effects of antibiotics to promote 
resistance gene development in the aquatic environment. 
(3) To study influence of ERY or ERY-H2O in the μg/l range on the microbial 
communities of the three SBRs.  The 16S rRNA gene-based uncultured methods, 
including terminal restriction fragment length polymorphism (T-RFLP), denaturing 
gradient gel electrophoresis (DGGE), and PhyloChip microarray, are used to 
statistically evaluate shift of microbial communities and identify selected and 
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inhibited microbial taxa.  This study will substantiate the effects of low dose 
antibiotics to regulate microbes in WWTPs. 
 
1.3    Organization of thesis 
The thesis is subdivided into the following chapters, each defining a specific 
area of study that contributed to meeting the overall objective. Each chapter will 
contain individual introduction, materials and methods, results and discussion section 
specific to the area of study.  
• Chapter 2: Literature review 
This chapter provides a comprehensive review of the history of antibiotics and 
antibiotic resistance, the role of antibiotics and antibiotic resistance in nature, 
the occurrence and fate of antibiotics in aquatic environments, the effects of 
antibiotics on ecological function disturbance, resistance selection and 
microbial community shift in aquatic environment.  
• Chapter 3: Influence of trace ERY and ERY-H2O on carbon and 
nutrients removal and on resistance selection in SBRs 
This chapter demonstrates low dose of ERY and ERY-H2O affected the SBR 
performance in terms of carbon and nutrient removal via selection of resistant 
microorganisms. 
• Chapter 4: Proliferation of antibiotic resistance genes in microbial 
consortia of SBRs upon exposure to trace ERY or ERY-H2O  
This chapter exhibits the antibiotic resistance genes amplified by ERY and 
ERY-H2O at low concentrations, and highlights the formation of antibiotic 
resistance biofilm as a result of ERY imposing on SBR microbial consortia.   
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• Chapter 5: Decrease of bacterial diversity and enrichment of 
Betaproteobacteria in microbial consortia of SBRs exposed to trace ERY 
and ERY-H2O  
This chapter demonstrates the microbial community shift of SBRs due to sub-
inhibitory ERY and ERY-H2O. 
• Chapter 6: Conclusions and recommendations 























2.1     The history of antibiotics and antibiotic resistance 
The current knowledge on the antibiotic action modes and antibiotic resistance 
mechanisms is listed in Table 2.1.  Different antibiotics have different working 
mechanism when attacking bacteria.  The major targets of antibiotics include cell 
membranes (e.g., mupirocin), cell-wall biosynthesis enzymes and substrates (e.g., β-
lactams, vancomycin, and bacitracin), bacterial protein synthesis (e.g., 
chloramphenicol, tetracyclines, macrolides, clindamycin, aminoglycosides, linezolid, 
mupirocin, and fusidic acid), and bacterial nucleic acid replication and repair (e.g., 
rifampicin, and quinolones) (Davies and Davies, 2010; Morar and Wright, 2010).  
According to the action modes of antibiotics, antibiotics can also be classified as 
bactericidal (causing death of bacteria) or bacteriostatic (preventing bacterial growth), 
which is not an intrinsic property of a given antibiotic but depends on the target 
species and/or the drug concentration (Hancock, 2005).   
Mechanism of bacterial resistance to antibiotics can be defined in three main 
categories: the inactivation of the antibiotics by modification of its active chemical 
moiety (e.g., hydrolysis, phosphorylation, and glycosylation); the specific 
modification of the macromolecular target of antibiotics (e.g., by mutagenesis of key 
residues); and the prevention of antibiotics from reaching their targets through the 
excretion of antibiotic drugs via efflux pumps (Walsh, 2000).  The variability of 
antibiotic resistance genes in environmental bacteria is currently indentified as an 
evolution result of ancient mutation for more than two billion years (Aminov, 2009).  
However, the past 70 year-propagation of antibiotic resistance genes is mainly due to 
the horizontal transfer of these genes across both taxonomically close and distant 




Table 2.1 Modes of action and resistance mechanisms of antibiotics a  
Antibiotic class Antibiotics Antibiotic 
target 





































Lincosamides Clindamycin Translation Nucleotidylation, efflux, 
altered target 
Streptogramins Synercid Translation C-O lyase (type B 
streptogramins), 
acetylation (type A 
streptogramins), efflux, 
altered target 
Oxazolidinones Linezolid Translation Efflux, altered target 
Phenicols Chloramphenicol Translation Acetylation, efflux, 
altered target 




Pyrimidines Trimethoprim C1 metabolism Efflux, altered target 
Rifamycins Rifampin Transcription ADP-ribosylation, 
efflux, altered target 
Lipopeptides Daptomycin Cell membrane Altered target 
Cationic peptides Colistin Cell membrane Altered target, efflux 
a The references (Davies and Davies, 2010; Morar and Wright, 2010) 
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The 70-year development of antibiotic resistance is nearly synchronous 
with the discovery of antibiotics, which is the same as other pharmaceuticals have 
suffered.  The therapeutic usage of any pharmaceuticals is always coupled with 
the development of resistance to that drug.  When sulfonamides, the first effective 
antibiotics, were applied for infectious treatment in 1937, the specific antibiotic 
resistance mechanism has been reported in several years later.  In the 2010s, the 
therapeutic use of sulfonamides was overwhelmed (Davies and Davies, 2010).  
The synchronous history of antibiotics application in disease control and antibiotic 
resistance development can be divided into several decades as shown in Table 2.2.  
 The first era, named as the dark ages, is the period before 1940 when 
antibiotics had not been recognized by the people.  The second era, namely the 
primordial era, is the decade in the 1940s when the chemotherapy initiated with 
the sulfonamide antibiotics, such as penicillin, streptomycin, and tetracycline.  
The third decade of the 1950s is named as the golden era because in this period 
large numbers of antibiotics were discovered and used till today, e.g., Kanamycin, 
erythromycin, vancomycin.  In the fourth ten years of the 1960s, following the 
discovery of antibiotic fluoroquinolones, the amount of the new discovered 
antibiotics decreased, while the antibiotic resistant pathogens increased.  
Therefore, pharmacologist had to optimize the usage of these natural antibiotics to 
make up for the lack of new antibiotics.  Therefore, the fourth era of the 1960s is 
called the pharmacologic era.  In the later years, with the continuous increase of 
antibiotic resistant pathogens and the decrease of the discovery of natural 
antibiotics, people began to develop artificial antibiotics based on the 
understanding of the antibiotics and the resistance.  The biochemical era is the 
period in the 1970s that artificial modification of the chemical structures of 
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antibiotics to avoid resistance were carried out relying on the knowledge of the 
biochemical actions of antibiotics and resistance mechanisms.  In 1980s, the 
genetic studies of antibiotic targets led to design new compounds to avoid 
resistance.  Therefore, the period is called the target era.  In 1990s, the genomic 
screening methodology applied on pathogens was used to predict essential targets 
of antibiotics, and the high-throughput screening (HTS) assays on large amount of 
artificial antibiotics were used to select relevant antibiotics, which is called the 
Genomic HTS era.  The following 2000s till now is called as the disenchantment 
era, since many companies disenchanted in the genome-based discovery programs 
on antibiotics because of the failure.  In a word, the efforts to develop or modify 
antibiotics to avoid resistance have failed, because antibiotic resistance gene 
transferring across the entire biosphere occurred more easily and rapidly than the 
development of new antibiotics.   
The development and distribution of antibiotic resistance genes among the 
microbial communities in the entire biosphere are believed to be accelerated by 
anthropogenic activities, such as the underuse, overuse, and misuse of antibiotics 
(Aminov, 2009; Davies and Davies, 2010).  Therefore, efforts have been made to 
study the relationships between the low concentrations of antibiotics discharged 
by anthropogenic activities and the proliferation of antibiotic resistance genes.  
Before carrying out this investigation, it is also necessary to understand the roles 
of low concentrations of antibiotics in the natural ecosystems, as well as to 
recognize the development mechanisms of antibiotic resistance genes in the 
natural environments.  
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Table 2.2 History of antibiotic discovery and concomitant development of antibiotic resistance a  
 
Time Era name Era description Antibiotics discovered Resistance 
Pre-1940 Dark ages Pre-antibiotic era   
1940s Primordial Advent of chemotherapy via the sulfonamides  Penicillin, streptomycin, tetracycline  
1950s Golden Most of the antibiotics used today were discovered Kanamycin, erythromycin, vancomycin  
1960s Pharmacologic Attempts were made to understand and improve the 
use of antibiotics by dosing, administration, etc. 
Fluoroquinolones, followed by a period of 
the low point of new antibiotic discovery 
and development 
increasing 
1970s Biochemical Knowledge of the biochemical actions of antibiotics 
and resistance mechanisms led to chemical 
modification studies to avoid resistance 
1980s Target Mode-of-action and genetic studies led to efforts to 
design new compounds 
1990s Genomic HTS Genome sequencing methodology was used to 
predict essential targets for incorporation into high-
throughput screening (HTS) assays 
2000s Disenchantment With the failure of the enormous investment in 
genome-based methods, many companies 
discontinued their discovery programs 
Synercid, linezolid 
a Adapted from the references (Davies and Davies, 2010; Wright, 2010)
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2.2     The role of antibiotics and antibiotic resistance in nature 
2.2.1    Updated knowledge on the roles of antibiotics and antibiotic resistance in 
nature 
Since unavoidable antibiotic resistance always emerges rapidly after the 
anthropogenic usage of a drug, concerns on the roles of antibiotics and the origin and 
evolution of the antibiotic resistance in natural ecosystems are increasing.  Previously, 
antibiotics were considered as a competition mechanism of antibiotics-producing 
bacteria or fungi to gain a larger share of environmental substrate supplies by killing 
competitors in their survival areas (Hancock, 2005).  Therefore, higher to lethal 
concentrations of antibiotics were applied in the therapies to act as a stress to inhibit 
or kill microorganisms.  Currently, investigations on the antibiotic resistance in 
environmental compartments have shed new light on the roles of antibiotics and 
antibiotic resistance in the nature.  Different from therapeutically relevant 
concentrations of antibiotics that play roles to eliminate competitive microorganisms, 
the non-clinical or sub-inhibitory concentrations of antibiotics in the natural 
environment are recognized to play a universal signaling role in intra- and inter-
domain communication in various ecosystems to select and survive adaptive 
phenotypic and genotypic microbes (Davies et al., 2006; Linares et al., 2006; 
Martinez, 2008; Yim et al., 2006).  Therefore, the antibiotic resistance cannot be 
simply explained as the resistant mechanisms to the inhibitory or toxic effects of 
antibiotics.  Instead, the antibiotic resistance can be generally defined as the universal 
microbial responses to the signaling effects of chemical compounds excreted by 
bacteria, fungi or more types of microbes.  The signaling chemicals may include 
compounds other than the antibiotics known today.  This may be one of the reasons to 
explain the phenomena in which antibiotic resistance genes have been found to be 
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persistent in the apparently antibiotic-free environments.  The microbial responses to 
antibiotic signaling are identified in two categories as phenotypic responses and 
genotypic responses.  
 
2.2.2    Antibiotic resistance roles – phenotypic responses to antibiotic signaling 
It is not clear on the effective concentrations of antibiotics to induce cross-talk 
in natural environments.  In lab-scale studies, however, bacterial responses to 
antibiotics were found to be concentration-dependent.  Higher concentrations of 
antibiotics (mg/L levels) bring out a stress response, while lower concentrations of 
antibiotics (from ng/L to µg/L levels) regulate a specific set of genes in bacteria 
(Davies et al., 2006).  These specific set of genes not only include those known to 
encode antibiotic resistance, but also include those encoding the transcriptional 
responses that may be converted into the phenotypes related to the pathogenic 
properties of bacteria.  
  Most of the bacteria that have been studied in labs on response to sub-
inhibitory antibiotics are pathogens, among which the best-studied model is 
opportunistic pathogen Pseudomonas aerugenosa.  One of the important pathogenic 
properties of P. aerugenosa is associated with the alginate overproduction and biofilm 
formation that are regulated by the quorum-sensing (QS) system.  It has been reported 
that the low concentrations of antibiotics can regulate pathogenic properties of P. 
aerugenosa through QS system (Aminov, 2009).  The lab studies on the responses of 
P. aerugenosa to sub-inhibitory concentrations of antibiotics, β-lactam antibiotics 
ceftazidime and imipenem, demonstrated contradictory effects of the two antibiotics 
on the decrease/increase alginate production and biofilm volume of P. aerugenosa 
(Aminov, 2009).   This indicates that antibiotics even with the same molecular target 
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at their higher concentrations can result in conflicting impacts on alginate production, 
thereby suggesting that antibiotics have distinct action modes at sub-inhibitory and 
higher concentrations.  In general, the factors that affect the regulation outcomes of 
low concentrations of antibiotics are complex and are largely unknown.  Thus, the 
phenotypic responses of bacteria to sub-inhibitory concentrations of antibiotics need 
more investigation.  
 
2.2.3    Antibiotic resistance roles – genotypic responses to antibiotic signaling 
In contrast to phenotypic responses of bacteria to low concentrations of 
antibiotics that are inconclusive, genotypic responses are consistent in the conclusion 
that resistance gene transfer is highly possible to be enhanced by similar or unrelated 
antibiotics, and that low-dose antibiotics may result in the increase of mutation rates 
(Aminov, 2009).  This may explain why antibiotic resistance genes exist in worldwide 
environment where low concentrations of antibiotics are detected.  However, the 
correlation of input of antibiotics at lower environmental concentrations with the 
development or occurrence of antibiotic resistance genes is short of support with 
experimental data (Kummerer, 2009b).  Other findings indicate that continuous input 
of resistant bacteria and resistance genes rather than the presence of antibiotics at sub-
inhibitory concentrations may be more important for keeping resistance in the 
environment (Ohlsen et al., 2003; Ohlsen et al., 1998).  Therefore, investigations are 
needed to clarify the causal effects of trace antibiotics on the development of 
antibiotic resistance genes in the aquatic and terrestrial environment. 
On the other side, the new concept of antibiotic resistome has significantly 
expanded our understanding on the antibiotic resistance, and may help us to explicate 
the effects of sub-inhibitory concentrations of antibiotics on the proliferation of 
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antibiotic resistance.  The antibiotic resistome is defined as a collection pool of all 
genes that contribute directly or indirectly to resistance, including four levels of genes 
as clinical, environmental, intrinsic and protoresistance  (Wright, 2010).  The 
interlock relationship of different levels of antibiotic resistance was shown in Fig. 2.1.  
The best-studied antibiotic resistance exists in the clinically important strains, which 
comprises a small part of genes associated with the resistance.  The second level of 
antibiotic resistance is distributed in a large amount of environmental bacteria, 
especially antibiotic producers.  The environmental resistome are more diverse than 
the clinical resistome, and serve as a reservoir of the clinical resistome.  The third 
level of resistance is the intrinsic resistance contained by bacteria, such as efflux 
systems prevalent on gram-negative bacteria can also perform as efflux pumps of 
antibiotics.  The most broad and higher level of resistance is the protoresistome, 
which encode metabolic proteins unrelated or a bit related to antibiotic resistance, but 
that can be evolved into resistance genes.  The protoresistome serves as a pool of 
precursors of antibiotic resistance.  The resistome describes the multiple sources of 
antibiotic resistance widely distributed in the environments, and may explain why 
resistance emerges so rapidly after antibiotic application in the clinic pathogens.  
Moreover, the resistance gene-containing strains could have high fitness in the 
antibiotics-absent environments, therefore, resistance genes are not easily lost and 
continue to persist when antibiotic pressure is not present (Andersson, 2006; Enne et 
al., 2004; Enne et al., 2005; Lenski, 1997; Luo et al., 2005).  However, it is largely 
unknown how the antibiotics-regulated cross-talk occurs in natural environments.  
The knowledge on the influence of antibiotics on the microorganisms in the 





Fig. 2.1  The antibiotic resistome (Wright, 2010) 
    
2.3     The occurrence and fate of antibiotics in aquatic environment, especially in 
sewage treatment processes  
2.3.1    The origins and dissemination of antibiotics in the environment 
Most antibiotics are naturally produced by the microorganisms in the soil.  
The concentrations of these antibiotics in the soil are dependent on the density of the 
antibiotic producers in the environment.  In aquatic environment, the density of 
microorganisms is lower than that in the soil; thereby the concentrations of these 
naturally-produced antibiotics in these compartments may be even lower.  Up to now, 
there is no report on the concentrations of antibiotics naturally produced in the aquatic 
environment.  It is believed that the main source of pharmaceuticals, including 
antibiotics in the environment, is the anthropogenic input (Kummerer, 2009a).  The 
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massive production and application of antibiotics in recent years greatly enhance the 
dissemination of antibiotics into every part of the environments. 
Once antibiotics are produced in the factories, they begin to contact 
directly/indirectly with human beings (Fig.2.2).  Besides the intentional disposal of 
precursors, byproducts, and unused drugs of antibiotics into sewage and soil, the 
antibiotics present in the environment are largely due to human, animals and 
aquaculture excretion, as well as agriculture applications.  Not all active antibiotics 
are completely metabolized during therapeutic use, and then both unchanged and 
metabolized drugs enter sewage and soil (Hirsch et al., 1999; Kummerer, 2009a).  In 
sewage treatment plants, since most antibiotics are not readily degradable, the 
antibiotics and their derivatives cannot be completely removed from liquid sewage 
through conventional processes of WWTPs.  Even the antibiotics adsorbed to the 
solid activated sludge of WWTPs will be excreted into sewage effluent again during 
the period of excess sludge digestion (Le-Minh et al., 2010).  Therefore, untreated 
antibiotics and their structure-close derivatives may subsequently enter into surface 
water, further run into the sources of drinking water, and lead to the increase of the 
occurrence of antibiotic resistance genes and resistance gene-containing bacteria.  
Similarly, unused antibiotics and their derivatives in manure, sediments and digested 
activated sludge are finally applied on soil as the manure.  The runoff of rain and 
irrigation may play crucial roles to disseminate these chemicals into surface water, 
ground water and water source.  Whatever routes the antibiotics and their derivatives 
have transferred, these compounds are persistent in the environment. Therefore, these 
persistent antibiotics may be recycled to contact with people, animal and plants again.  
The long-term effect would be that the antibiotic resistance maintains in certain levels 




Fig. 2.2  Origins and dissemination of antibiotics in the environment.  Summarized 
according to the reference (Kummerer, 2009a). 
 
2.3.2    The occurrence and fate of antibiotics in conventional WWTPs and 
downstream receiving water bodies  
As the main collection pools of antibiotics and antibiotic resistant bacteria, 
WWTPs are posing increasing threat to human beings because of the wide usage of 
the recycled wastewater (e.g., as portable and non-portable water sources) (Le-Minh 
et al., 2010).  The occurrence levels of antibiotics in raw sewage, effluent of 
coventioanl WWTPs, and downstrean reveiving water bodies (e.g., surface water and 
ground water) are summarized in Table 2.3.   
The detected concentrations of specific antibiotics in raw sewage differed 
between countries, possibly reflecting variable prescription practices, as well as the 
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various degrees of dilution due to differences in per-capita water consumption (Le-
Minh et al., 2010; Miao et al., 2004).  For example, since sulfamethoxazole is one of 
the top 15 pharmaceuticals sold in China, its concentrations were reported as high as 
7.91 µg/L in sewage influent (Peng et al., 2006).  For macrolides, clarithromycin is 
more often detected in WWTPs effluents at higher concentrations than erythromycin-
H2O and roxythromycin in Switzerland, whereas erythromycin-H2O is more 
frequently detected than clarithromycin and roxythromycin in Canada, which is  well 
correlated to consumption pattern (Gobel et al., 2007; Miao et al., 2004). 
The removal efficiency of antibiotics in conventional WWTPs is dependant on 
both the properties of antibiotics and the processes of WWTPs.  Through hydrophobic  
interactions with organic-rich sewage sludge, hydrophobic antibiotics can be removed 
from liquid phase more efficiently than hydrophilic chemicals (Beausse, 2004).  
Antibiotics can also be transferred from aqueous solution onto solid sludge via ion 
exchange, complex formation with metal ions, and polar hydrophilic interaction 
(Diaz-Cruz et al., 2003).  For example, macrolides are removed mainly by sorption to 
sewage sludge in WWTPs via hydrophobic interactions and cation exchanges due to 
its surfactant-like structure, and their average removal efficiency can be up to 50% for 
clarithromycin and azithromycin (Yasojima et al., 2006).  Fluoroquinolones are 
predominantly removed by adsorption to sludge, and their removal efficiency is 
reported to be 88–92% (Golet et al., 2003). 
Besides the above mentioned sorption mechanisms, antibiotics can also be 
transformed by hydrolysis and further biotransformation in WWTPs.  For example, 
the cyclic amide of all β-lactam drugs is highly susceptible to be hydrolyzed 
chemically or enzymatically (Deshpande et al., 2004).  The chemical hydrolysis of β-
lactam penicillin can occur with acid, alkaline, and even nucleophiles (water or metal 
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ions).  The β –lactamases are the enzymes contained by many species of bacteria to 
hydrolyze β-lactams.  In WWTPs, β-lactams can be significantly bio-degraded 
through biological processes, and β-lactams are rarely detected in the effluent of 
WWTPs (Watkinson et al., 2007).  Besides β-lactams, sulfonamides that are adsorbed 
to the sludge can be effectively removed by biodegradation in the process of 
anaerobic digestion (Carballa et al., 2006).   
The biotransformation of antibiotics are significantly affected by operating 
conditions of WWTPs (Beausse, 2004).  For example, the increase of solids retention 
time (SRT) and  hydraulic retention time (HRT) are expected to provide sufficient 
enrichment and reaction time for slower growing bacteria, which may be capable of 
transforming antibiotics (Clara et al., 2005; Jones et al., 2007; Kim et al., 2005; 
Tauxe-Wuersch et al., 2005; Vieno et al., 2007; Yasojima et al., 2006).  Removal 
efficiency of trimethoprim can be improved in WWTPs with longer SRT, because 
nitrification micriorganisms have been reported to degrade trimethoprim (Batt et al., 
2006; 2007; Perez et al., 2005).  Moreover, SRT is also a factor to affect the 
biosorption of antibiotics, because the change of activated sludge characters may 
influece the biosorption ability of sludge.  Shorter SRT has been reported to 
significantly reduce the removal efficiency of tetracycline (Kim et al., 2005).  
In summary, conventional WWTPs processes appear to be variable in 
removing antibiotics, and antibiotics adsorbed to activated sludge are expected to be 
released into liquid phase during the processes of anaerobic sludge digestions.  As a 
result, antibiotics are detected in downstream surface water and ground water, where 
the antibiotic resistance genes is also expected to be proliferated due to the presence 
of antibiotics (Adelowo et al., 2008). 
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Table 2.3 Measured concentrations of antibiotics in the water environments a  
Group /Antibiotics IF (ng/l)  EF (ng/l)   Removal 
efficiency (%) 
Main process of WWTPs SW (ng/l)  GW  (ng/l)  References 
β-lactam          
Cephalexin 2000 80 96 Activated sludge system 
(AS)  
   (Costanzo et al., 2005)  
 ≤5600  <(2)  –  AS     (Watkinson et al., 2007)  
 670–2900  240–1800  9– 89 Chemical enhanced / 
Secondary treatment  
   (Gulkowska et al., 2008) 
 1563–4367  10–994  36–99.8 Secondary treatments/UV or 
chlorination  
   (Lin et al., 2009) 
Amoxicillin ≤280  <(3) 30  –  AS     (Watkinson et al., 2007)  
Cloxacillin <(1)–320  <(1)  –  AS     (Watkinson et al., 2007) 
 <(13)–15  <(9)  –  Secondary treatment / 
Chlorination  
   (Cha et al., 2006) 
Penicillin G <(2)  <(2)  –  AS  up to 3   (Watkinson et al., 2007; Färber, 2002) 
Penicillin V ≤160  ≤80  –  AS  up to 3   (Watkinson et al., 2007; Färber, 2002) 
Flucloxacillin     7  (Christian et al., 2003) 
Piperacillin     48  (Christian et al., 2003) 
Sulfonamides        
Sulfamethoxazole 1090 210 81 AS/chlorination  up to 163  up to 410  (Yang et al., 2005; Sacher et al. 2002) 
 450 <(30)  >93 AS  up to 480  up to 470  (Choi et al., 2007; Hirsch et al., 1999) 
 5450–7910  <100  >98  AS/filtration/chlorination  up to 52   (Christian et al., 2003; Peng et al., 2006) 
 590 0.39 33 AS  up to 1900   (Gros et al., 2006; Kolpin et al., 2002) 
 230–570  210–860  –  AS/Sand filtration     (Gobel et al., 2005)  
 390 0.31 20 AS     (Brown et al., 2006)  
 <(50)–1250  <(50)–210  18–100 AS     (Bendz et al., 2005; Karthikeyan and 
Meyer, 2006) 
 20 70 –  AS/Chemical P removal     (Bendz et al., 2005) 
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Group /Antibiotics IF (ng/l)  EF (ng/l)   Removal 
efficiency (%) 
Main process of WWTPs SW (ng/l)  GW  (ng/l)  References 
 580 250 67 AS     (Carballa et al., 2004) 
 0.6 NA  57 AS     (Carballa et al., 2005) 
 <(80)–674  <(80)–304  42 Chemical P removal/AS     (Lindberg et al., 2005) 
 24–145 18–91 – 279 to 66 AS     (Clara et al., 2005) 
 10–118 9–78 34–63 AS or Chemical enhanced / 
UV or chlorination  
   (Xu et al., 2007a) 
 179–1760  47–964  26–88 Secondary treatments/UV or 
chlorination  
   (Lin et al., 2009) 
N4-sulfamethoxazole 850–1600  <(20)–180  –  AS/Sand filtration    (Gobel et al., 2005) 
Sulfathiazole 10 570  180 98 AS  up to 130   (Choi et al., 2007; Kolpin et al., 2002) 
Sulfamethazine 150 <(30)  >80 AS/chlorination   up to 160  (Hirsch et al., 1999; Yang et al., 2005) 
 4010 <(30)  >99 AS  up to 220   (Choi et al., 2007; Kolpin et al., 2002) 
Sulfadimethoxine 70 <(30)  >57 AS/chlorination  up to 60   (Kolpin et al., 2002; Yang et al., 2005) 
 460 <(30)  >93 AS     (Choi et al., 2007) 
Sulfadiazine 5100–5150  <(150)  > 97  AS/filtration/chlorination   up to 17   (Peng et al., 2006; Sacher et al. 2002) 
 <(1)–72  <(1)–36  50 AS or Chemical 
enhanced/UV or chlorination  
  (Xu et al., 2007a) 
Sulfamerazine 1530 < (30)  > 98  AS    (Choi et al., 2007) 
Sulfadimidin      up to 23  (Sacher et al., 2002) 
     up to 7   (Christian et al., 2003) 
Trimethoprim         
Trimethoprim 1172 290 75 AS  up to 24   (Gros et al., 2006; Sacher et al., 2002) 
 210–440  20–310  64 AS  up to 200   (Gobel et al., 2005; Hirsch et al., 1999) 
 0.59 180 70 AS  up to 12   (Brown et al., 2006; Christian et al., 
2003) 




Group /Antibiotics IF (ng/l)  EF (ng/l)   Removal 
efficiency (%) 
Main process of WWTPs SW (ng/l)  GW  (ng/l)  References 
 80 40 49 AS/chemical P removal    (Bendz et al., 2005)  
 213–300 218–322  – 3 Trickling filter/AS/UV    (Roberts and Thomas, 2006) 
 99–1300  66–1340  3 Chemical P removal/AS    (Lindberg et al., 2005) 
 120–320  120–230 – 17 to 62 Chemical enhanced / 
Secondary treatment  
  (Gulkowska et al., 2008) 
 259–949  203–415  22–56  Secondary treatments/UV or 
chlorination  
  (Lin et al., 2009) 
Tetracyclines        
Doxycycline 210 70 67 AS/chlorination    (Yang et al., 2005) 
 220 30 86 AS    (Choi et al., 2007) 
 <(64)–2480  <(64)–915  70 Chemical P removal/AS    (Lindberg et al., 2005) 
Tetracycline 200 < (30)  >85 AS/chlorination  up to 110   (Kolpin et al., 2002; Yang et al., 2005) 
 110 <(0.03)  >73 AS    (Choi et al., 2007)  
 240–790  <(50)–160  68–100 AS    (Karthikeyan and Meyer, 2006) 
 96–1300  180–620  – 88 to 73  Chemical enhanced / 
Secondary treatment  
  (Gulkowska et al., 2008) 
 46–234 16–38 66–90 Secondary treatments/UV or 
chlorination  
  (Lin et al., 2009) 
Chlortetracycline 270 60 78 AS/chlorination  up to 690   (Kolpin et al., 2002; Yang et al., 2005) 
 970 40 96 AS    (Choi et al., 2007) 
Oxytetracycline 240 <(30)  >88 AS  up to 340   (Choi et al., 2007; Kolpin et al., 2002) 
     up to 19.2   (Calamari et al., 2003) 
        
Chinolones        
Ciprofloxacin   up to 100    up to 5   (Färber, 2002)  




Group /Antibiotics IF (ng/l)  EF (ng/l)   Removal 
efficiency (%) 
Main process of WWTPs SW (ng/l)  GW  (ng/l)  References 
 90–300 <(6)–60  87 Chemical P removal/AS  up to 30   (Kolpin et al., 2002; Lindberg et al., 
2005) 
 90 130 – 44 AS  up to 26.2   (Calamari et al., 2003; Costanzo et al., 
2005)  
 320–570  60–90 83 AS/Fe flocculation    (Golet et al., 2003)  
 320 31.5 90 AS/Chemical P removal/sand 
filtration  
  (Zorita et al., 2009) 
 80 27 66 Secondary treatment    (Xiao et al., 2008) 
Norfloxacin 340–520  40–60 88 Act. Sludge/Fe flocculation  up to 120   (Golet et al., 2003; Kolpin et al., 2002) 
 66–174 <(7)–37  87 Chemical P removal/AS    (Lindberg et al., 2005)  
 18 <(5.5)  >70 AS/Chemical P removal/sand 
filtration  
  (Zorita et al., 2009) 
 110–460  85–320  – 20 to 78  Chemical 
enhanced/Secondary 
treatment  
  (Gulkowska et al., 2008) 
 54–263 27–85 50–82 AS or Chemical 
enhanced/UV or chlorination  
  (Xu et al., 2007a) 
 339 85 75 Secondary treatment    (Xiao et al., 2008) 
Ofloxacin <(43)  <(43)  –  AS    (Gros et al., 2006) 
 3520–5560  <(80)–740  >85 AS/filtration/chlorination  20  (Alexy et al., 2006; Peng et al., 2006) 
 470 110 77 AS    (Brown et al., 2006)  
 <(6)–287  <(6)–45  86 Chemical P removal/AS    (Lindberg et al., 2005) 
 22.5 10 56 AS/Chemical P removal/sand 
filtration  
  (Zorita et al., 2009) 
 80–368  41–165 40– 70 AS or Chemical 
enhanced/UV or chlorination  
  (Xu et al., 2007a) 
 115–1274  53–991  <88 Secondary treatment/UV or 
chlorination  
  (Lin et al., 2009) 
 1208 503 58 Secondary treatment    (Xiao et al., 2008) 
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Group /Antibiotics IF (ng/l)  EF (ng/l)   Removal 
efficiency (%) 
Main process of WWTPs SW (ng/l)  GW  (ng/l)  References 
Macrolides        
Erythromycin <(20)  <(20)  –  AS   up to 49  (Gros et al., 2006; Sacher et al., 2002) 
 60–190 60–110 –  AS  up to 1700   (Gobel et al., 2005; Hirsch et al., 1999) 
 <(50)–1200  <(50)–300  44–100 AS or aerated lagoon  up to 190   (Alexy et al., 2006; Karthikeyan and 
Meyer, 2006)  
 71–141 145–290 – 79  Trickling filter/Act. 
sludge/UV  
up to 1700   (Kolpin et al., 2002; Roberts and 
Thomas, 2006) 
 470–810  520–850  – 12 to 19 Chemical 
enhanced/Secondary 
treatment  
up to 15.9   (Calamari et al., 2003; Gulkowska et al., 
2008)  
 253–1978  216–2054  15–45 AS or Chemical 
enhanced/UV or chlorination  
  (Xu et al., 2007a)  
 226–1537  361–811  <56 Secondary treatments/UV or 
chlorination  
  (Lin et al., 2009) 
Roxithromycin 10–40 10–30 –  AS/sand filtration   up to 26  (Gobel et al., 2005; Sacher et al., 2002) 
 1500 870 42 AS or aerated lagoon  up to 560   (Hirsch et al., 1999; Karthikeyan and 
Meyer, 2006) 
 25–117 36–69 – 80 to 44 AS  up to 14   (Alexy et al., 2006; Clara et al., 2005) 
 75–164 35–278 53–76 AS or Chemical 
enhanced/UV or chlorination  
up to 180   (Kolpin et al., 2002; Xu et al., 2007a) 
Clarithromycin 330–600  110–350  21 AS/sand filtration  up to 65   (Giger et al., 2003; Gobel et al., 2005) 
 492–883  266–444  43 AS  up to 260   (Hirsch et al., 1999; Yasojima et al., 
2006) 
 59–1433  12–232 <0 to 99 Secondary treatments/UV or 
chlorination  
up to 37   (Alexy et al., 2006; Lin et al., 2009) 
     up to 20.3   (Calamari et al., 2003) 
Azithromycin 199–371  88–219 49 AS  up to 3   (Alexy et al., 2006; Yasojima et al., 
2006) 
Others        
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Group /Antibiotics IF (ng/l)  EF (ng/l)   Removal 
efficiency (%) 
Main process of WWTPs SW (ng/l)  GW  (ng/l)  References 
Ronidazol      up to 10  (Sacher et al., 2002) 
Chloramphenicol  up to 68      (Christian et al., 2003) 
  up to 560    up to 60   (Hirsch et al., 1999) 
Clindamycin  up to 110      (Christian et al., 2003) 
     up to 24   (Alexy et al., 2006) 
Lincomycin     up to 730   (Kolpin et al., 2002) 
     up to 248.9   (Calamari et al., 2003) 
Spiramicin     up to 74.2   (Calamari et al., 2003) 
Oleandomycin     up to 2.8   (Calamari et al., 2003) 
Tylosin     up to 280   (Kolpin et al., 2002) 
     up to 2.8   (Calamari et al., 2003) 
a Summarized from the references (Kummerer, 2009a; Le-Minh et al., 2010) 
Value in the parenthesis is the limit of detection in each study.  AS: activated sludge 
Abbreviations: IF, EF influent and effluent water of sewage treatment plant, SW surface water, GW ground water 
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2.4     The effects of antibiotics on ecological function disturbance, resistance 
selection and microbial community shift in aquatic environment  
Most of antibiotics and their metabolites are persistent in the environments, 
even in the manually enhanced biological treatment processes of WWTPs. The 
persistent antibiotics and derivatives are believed to play roles as ecological factors 
that could induce phylogenetic structure alteration, resistance expansion, and 
ecological function disturbance of environmental ecology (Ding and He, 2010).  
Compared to soil compartments, however, fewer studies have been conducted on 
WWTPs.  In WWTPs, the lower concentrations of antibiotics, higher mobility of 
microbes, and the masking of larger quantities of antibiotic resistance genes and 
resistant bacteria input into the aquatic environment have resulted in less pronounced 
effects of antibiotics being discovered hardly (Ding and He, 2010).  Since signaling 
and regulatory roles of sub-inhibitory antibiotics on microbes have been recognized 
recently, studies of antibiotic influence on WWTPs were rarely related to the contents, 
which are not necessarily weaker in aquatic ecosystem than in soil.  Therefore, in 
order to shed light on microbial responses to antibiotic signaling, it is imperative to 
study the influence of low-dose antibiotics on complex microbial consortia of 
WWTPs, in terms of bacterial performance interruption, microbial community shift, 
and antibiotic resistance proliferation.   
 
2.4.1    The effects of antibiotics on ecological function disturbance and on 
microbial community shift in aquatic environment 
Antibiotics are frequently detected in sewage in the concentrations of ng/L and 
μg/L ranges (Le-Minh et al., 2010).  These concentrations are not considered to be 
high enough to cause noticeable effects on wastewater treatment processes.  However, 
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the higher concentrations (mg/L ranges) of antibiotics have been reported to impose 
inhibitory impacts on the microbial activities in WWTPs.  The sulfonamide antibiotics 
(10–400 mg/L) have been reported to inhibit microbial activities in activated sludge 
by more than 20% (Ingerslev and Halling-Sorensen, 2000).  Nitrogen transformation 
process has been best-studied.  Streptomycin at 400 mg/L can achieve 75% inhibition 
on ammonia oxidation in activated sludge (Tomlinso.Tg et al., 1966).  
Oxytetracycline has shown to inhibit nitrification process in surface water (Klaver and 
Matthews, 1994).  In anaerobic processes, erythromycin of 1 mg/L has been reported 
to reduce COD removal efficiency and biogas production by about 5% (Amin et al., 
2006).  Metronidazole (6 mg/L) could reduce anaerobic activity by 69% (Gartiser et 
al., 2007a).  Moreover, methanogenesis has been reported to be inhibited by 
antibiotics sulfamethoxazole and ofloxacin in an anaerobic digestion process 
(Fountoulakis et al., 2004).  Ofloxacin has been found to inhibit both processes of 
methanogenesis and acetogenesis (Fountoulakis et al., 2008).  In contrast, even with 
longer reaction time up to 80 h, ampicillin (250 mg/L), benzylpenicillin (250 mg/L), 
novobiocin (150 mg/L), oxytetracycline (250 mg/L), and chloramphenicol (50 mg/L) 
have shown no effect on either biomass or nitrate production in a stabilized nitrifying 
sludge (Gomez et al., 1996).  In some cases when a complex mixture of bacteria has 
been exposed to antibiotics, however, increased nitrification activity can be observed 
with the reason not yet clear (Halling-Sorensen, 2001).   
Then what are the responses of microorganism to antibiotics at low 
concentrations?  The microbial community structures of WWTPs are highly possible 
to shift in the way that antibiotic sensitive bacteria are substituted by resistant bacteria, 
which may be intrinsic resistance or achieve resistance genes via horizontal gene 
transfer due to antibiotic pressure (Ding and He, 2010; Szczepanowski et al., 2009).  
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For example, tetracycline resistant bacteria have been shown to increase in 
sequencing batch reactor exposure to tetracycline of 1 mg/L (Kim et al., 2007).  
Bacteria resistant to ciprofloxacin, trimethoprim, sulfamethoxazole and vancomycin 
have been found in wastewater influent and effluent, such as fecal coliforms, E.coli 
and enterococci (Nagulapally et al., 2009).  Most importantly, resistant bacteria are 
highly possible to play similar ecological functions as the substituted sensitive 
bacteria in the complex systems, although they belong to same or distinct species 
(Ding and He, 2010).  Consequently, the selection of resistant bacteria can offset the 
inhibitory impact of antibiotics on the functional bacteria associated with the 
performance of WWTPs.  Nevertheless, it is still inconclusive on the actual 
significance of low concentrations of antibiotics in WWTPs in term of resistance 
propagation.  Therefore, it is necessary to study the effects of low levels of antibiotics 
in WWTPs on the selection of resistance genes and resistant bacteria.  Further study is 
also needed to investigate the microbial community structure shift due to the presence 
of antibiotics at low concentrations. 
 
2.4.2    The effects of antibiotics on resistance selection in aquatic environment 
It is still under debate which factor is more important for the proliferation of 
antibiotic resistance in WWTPs, e.g., the input of resistant bacteria and resistance 
genes with wastewater, or the presence of ultra-low concentrations of antibiotics in 
wastewater.  However, it is consistent that massive antibiotic resistance genes have 
been detected in untreated sewage (US), activated sludge (AS) and effluent of 
WWTPs (EW), special wastewater (SW) from hospital, animal production, and 
aquaculture area, natural water (NW), sediments (SD) and drinking water (DW) as 
shown in Table 2.4.    
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The antibiotic resistance genes detected in the WWTPs include those resistant 
to all kinds of antibiotics used today, e.g., aminoglycoside, β-lactam, chloramphenicol, 
fluoroquinolone, macrolide, rifampicin, tetracycline, trimethoprim and sulfonamide, 
as well as multidrug efflux genes and small multidrug resistance genes 
(Szczepanowski et al., 2009; Zhang et al., 2009).  Also, the spectra of antibiotic 
resistance genes detected in activated-sludge and in effluent of sewage are quite 
similar.  The same genes resistant to fluoroquinolone, trimethoprim and sulfonamide, 
as well as the same genes for multidrug efflux systems have been detected in both 
activated sludge and the effluent (Szczepanowski et al., 2009).  The only difference is 
that the detected numbers of genes resistant to aminoglycoside, β-lactam, macrolide 
and tetracycline are slightly less in final effluent than in the activated sludge 
(Szczepanowski et al., 2009).  This indicates that sewage treatment processes used in 
the WWTPs are not effective to remove antibiotic resistance genes, especially 
fluoroquinolones, trimethoprim and sulfonamides resistance genes.  The persistence 
of antibiotic resistance genes is consistent with the persistence of antibiotics in the 
WWTPs.  Fluoroquinolones are predominantly removed by adsorption to sludge 
(Golet et al., 2003).  Trimethoprim are negligible to be removed by sorption to 
activated sludge; only in the WWTPs with longer SRT that allow nitrification 
microorganisms to sustain, biodegradation efficiency of trimethoprim by nitrifiers can 
be improved (Batt et al., 2006; 2007; Perez et al., 2005).  Sulfonamides that are 
sorbed to the sludge can be effectively removed by biodegradation in the process of 
anaerobic digestion, but not in the aerobic processes of WWTPs (Carballa et al., 
2006).  The presence of these antibiotics in activated sludge and in liquid sewage 
might exert selective pressure on bacteria within the sewage treatment system, leading 
to the enrichment of resistant bacteria/genes and their release into the environment 
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with the final effluents.  This is proved by the fact that antibiotic resistance genes can 
also be detected in bacteria obtained from the downstream WWTP, such as natural 
water and even drinking water,  indicating that these resistance genes have been 
further dispersed downstream WWTPs (Zhang et al., 2009).   
Moreover, some recently discovered resistance genes from clinical isolates 
were also detected in WWTPs, indicating exchanges of resistance genes between 
clinical and WWTPs bacteria.  These newly indentified resistance genes from clinical 
strains that are also detected in WWTPs include the aminoglycoside resistance genes 
aadA6/aadA10 and aac(3)-Id, the β-lactam resistance genes ctx-m-27, ctx-m-32, ges-3, 
imp-9, imp-13 and oxa- 58, and the fluoroquinolone resistance genes qnrA3, qnrB1 
and qnrS (Szczepanowski et al., 2009).  The results suggest that WWTP bacteria are a 
reservoir for various resistance genes that are collected from clinical sources.  The 
clinically relevant resistant bacteria and genes may be further disseminated to natural 
environments.  Therefore, it is crucial to clarify how these resistance genes, under the 
selection of low levels of antibiotics, could transfer among bacteria and alter the 
microbial communities of WWTPs in order to maintain the level of resistance.   
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Table 2.4 Antibiotic resistance genes detected in the water environments a  
 
Gene name*  Gene product  Resistance to Detected in water 
environments 
aacA, aadB  Aminoglycoside 6'-N-acetyltransferase  Km, Tob, Ak   AS,EW 
aacA1  Aminoglycoside 6'-N-acetyltransferase  Gm, Km, Tob, 
Neo  
 AS 
aacA4  Aminoglycoside 6'-acetyltransferase  Ak  AS, NW 
aacA7  Aminoglycoside acetyltransferase-6' 
type I  
Gm, Tob, Km  AS 
aacA29b  Aminoglycoside 6'-N-acetyltransferase  Ak, Km  AS, EW 
aacC1  Aminoglycoside 3N-acetyltransferase  Gm  AS, EW,NW, SW, 
US 
aacC2  Aminoglycoside (3)-N-
acetyltransferase  




Gm  NW, SW, US 
aacC4  Aminoglycoside (3)-acetyltransferase 
IV  
Gm  AS, EW, NW, 
SW, US 
aac(3)-Id* 3'-N-Aminoglycoside acetyltransferase  Gm  AS, EW 
aac(69)-Im  6'-Aminoglycoside N-acetyltransferase  Tob, Ak, Km  AS, EW 
aadA4, 
aadA5  
Streptomycin 3'-adenylyltransferase  Sm, Sp  AS, NW 
aadA7  Aminoglycoside (3')(9)-
adenylyltransferase  
Sm, Sp  AS, EW   
















Putative Sm, Sp  AS, DW, EW, 
NW, SD, SW, US 
aadD  Kanamycin-nucleotidyltransferase  Km  AS, EW   
aph  Aminoglycoside 3'-phosphotransferase  Km, Neo  AS, EW   
aphA  3'-Aminoglycoside phosphotransferase  Km  DW 
aphA-3  3'5'-Aminoglycoside 
phosphotransferase of type III  
Km  AS, EW   
aphA-6  3'-Aminoglycoside phosphotransferase  Km, Ak  AS, EW   
aph2  Aminoglycoside-3'-O-
phosphotransferase  
Km, Neo  AS, EW   
aph(29)-Ib  Aminoglycoside phosphotransferase  Km  AS 
strA  Aminoglycoside 3'-phosphotransferase  Sm  AS, NW, SW 
strB  Aminoglycoside 6-phosphotransferase  Sm  AS, NW 
ctx-m-4  Class A β-lactamase Amp, Ctx, Cxm, 
Atm  
AS, EW   
ctx-m-27* Class A β-lactamase Caz, Ctx, Amo, 
Tic, Prl, Kf, 
Cxm, Cpo, Atm  
AS, EW   
ctx-m-32* Class A β-lactamase Amo, Ctx, Caz, 





Gene name*  Gene product  Resistance to Detected in water 
environments 
ges-3* Class A extended-spectrum β-lactamase  Titeracillin, Prl, 
Caz, Ctx, Atm, 
Ipm  
AS, EW   




shv-34  Class A β-lactamase  Caz, Ctx  AS, EW   
blaTEM-1  Class A β-lactamase  Amp, Pen-G  AS, EW   
blaTLA-2  Class A extended spectrum β-lactamase  Amo, Tic, Caz, 
Kf, Cxm, Fox, 
Ctx, Fep, Atm  
AS, EW   
veb-1  Class A extended-spectrum β-lactamase  Cephalosporins, 
Atm  
AS 
vim-4  Metallo-β-lactamase  β-lactamase EW   
imp-2, imp-5  Class B metallo β-lactamase  Amp, Ctx, Fep  AS, EW 
imp-9*, imp-
11  
Class B metallo β-lactamase  β-lactamase AS, EW   
imp-13, imp-
2  
Class B metallo β-lactamase  Cxm, Caz, Ctx, 
Cro, Fep, Amp  
AS, EW   
ampC  Class C β-lactamase, cephalosporinase  Pen, 
cephalosporins  
DW, NW, SW, US 
cmy-9, cmy-
10  
Class C β-lactamase  β-lactamase AS, EW   
cmy-13*, 
cmy-5  
Class C β-lactamase β-lactamase AS, EW 
blaNPS-1  Class D β-lactamase Amo, azlocillin, 
Cec, cefazolin, 
Cfp, Prl  
AS 
blaNPS-2  Class D β-lactamase Amp  AS, EW  
oxa-1  Class D β-lactamase β-lactamase AS, EW 
oxa-2, oxa-
21, oxa-53  
Class D β-lactamase β-lactamase AS, EW 
oxa-5  Class D β-lactamase β-lactamase AS, EW 
oxa-9  Class D β-lactamase β-lactamase AS 
oxa-10, oxa-
56  
Class D β-lactamase β-lactamase AS, EW  
oxa-12  Class D β-lactamase β-lactamase AS, EW  
oxa-20  Class D β-lactamase Amo, Tic  EW 
oxa-22  Class D β-lactamase Benzylpenicillin, 
Ob  
AS, EW  
oxa-27  Class D β-lactamase β-lactamase AS 
oxa-40  Class D β-lactamase Amo, Tic, Caz, 
Fep, Cpo, Prl, 
Kf, Cxm, Ipm  
AS, EW  
oxa-46, oxa  Class D β-lactamase Amp, Car, Mez, 
Kf  
AS, EW  
oxa-48  Class D β-lactamase Amo, Tic, Fep, 
Ipm, Cpo, Prl, 
Ctx  
AS, EW  
oxa-50  Class D β-lactamase Amp, Tic, Ctx, 
Prl, Kf, Cxm  
AS, EW  
oxa-58* Class D β-lactamase Amo, Tic, Cpo, 
Prl, Ipm, Kf  
AS, EW  
oxa-75  Class D β-lactamase Amp, Prl  AS, EW  
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Chloramphenicol efflux protein  Cm  AS 
cmlB  Hydrophobic polypeptide  Cm  AS 
cmxA  Chloramphenicol export protein  Cm  AS, EW  
fexA  Florfenicol/chloramphenicol exporter  Cm, Ffc  AS  
floR, cmlA  Efflux protein  Cm, Ffc  AS, EW, DW, 
NW, SW 
cat  Chloramphenicol acetyltransferase  Cm   AS, EW 
cat  Chloramphenicol acetyltransferase  Cm   AS, EW 
cat  Chloramphenicol acetyltransferase  Cm   AS, EW 
cat  Chloramphenicol acetyltransferase  Cm  AS, EW  
cat2, catII, 
cmlA  
Chloramphenicol acetyltransferase  Cm  AS, EW, SW 
catIII  Chloramphenicol acetyltransferase  Cm  AS, EW, NW 
catA  Chloramphenicol acetyltransferase  Cm   AS, EW 
catB2  Chloramphenicol acetyltransferase  Cm  AS, EW 
catB4  Chloramphenicol acetyltransferase  Cm  AS, EW  
catB6  Chloramphenicol acetyltransferase  Cm  EW 
catB7  Chloramphenicol acetyltransferase  Cm  AS, EW 
catB8  Chloramphenicol acetyltransferase  Cm  AS, EW  
cat-TC, cat  Chloramphenicol acetyltransferase  Cm  AS, EW  
qnrA3*, qnr  Pentapeptide family, DNA-gyrase and 
topoisomerase IV protection  




Pentapeptide family, DNA-gyrase and 
topoisomerase IV protection  
Cip  AS, EW  
qnrB4  Pentapeptide family  Quinolones  AS, EW  
qnr, qnrS2* Quinolone resistance determinant  Cip, Nor, Nal  AS, EW  
ereA2, ereA  Erythromycin esterase type I  Em  AS, EW  
ereB  Erythromycin esterase type II  Em  AS  
mph(B)  Macrolide phosphotransferase  Azi, Cla, Em, 
Rox, Tyl  
AS, EW  
mph(A)  Macrolide 2'-phosphotransferase I  Azi, Cla, Em, 
Rox  
AS, EW  
mph  Macrolide 2'-phosphostransferase  Em  AS, EW  
mph(B)  Macrolide 2'-phosphotransferase II  Macrolides  AS, EW  
mphBM  Macrolide 2'-phosphotransferase II  Macrolides  AS  
ermA  rRNA adenine N6-methyltransferase  Em  EW, SW 
ermB  rRNA adenine N6-methyltransferase  Em  EW, SW 
ermF  rRNA adenine N6-methyltransferase  MLS  EW, SW 
erm (C, E, T, 
V, X)  
rRNA adenine N6-methyltransferase  MLS  EW, SW 
mef(A)  Macrolide-efflux protein, MFS 
permease  
Em  AS 
mefE, mefI  Macrolide-efflux protein, MFS 
permease  
Em  AS  
mel  Macrolide-efflux protein, macrolide-
specific ABC-type efflux carrier  
Azi, Cla, Em  AS, EW 
msrA  Erythromycin resistance ATP-binding 
protein MsrA  
Em  AS  
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Gene name*  Gene product  Resistance to Detected in water 
environments 
arr2  Putative rifampicin ADP-
ribosyltransferase  
Rif  AS, EW  
sulA  Dihydropteroate synthetase  Sul  SD 
sulI  Dihydropteroate synthetase  Sul  AS, EW, DW, 
NW, SD, SW 
sulII  Dihydropteroate synthetase  Sul  AS, EW, DW, 
NW, SD, SW 
sul3  Dihydropteroate synthetase  Sul  AS, EW, NW, SD 
dfrII  Dihydrofolate reductase  Tp  AS, EW  
dfrV  Dihydrofolate reductase  Tp  AS, EW  
dfr5, dfr7  Dihydrofolate reductase  Tp  NW 
dfr12 Dihydrofolate reductase  Tp  DW, NW, SW 
dfr13(dfrXIII
)  
Dihydrofolate reductase  Tp  AS, EW  
dfr15 Dihydrofolate reductase  Tp  EW, NW 
dfr16  Dihydrofolate reductase  Tp  AS, EW  
dfr17, dfrVII  Dihydrofolate reductase  Tp  DW, NW 
dfr18 Dihydrofolate reductase  Tp  NW 
dfrA19  Dihydrofolate reductase  Tp  AS, EW  
dfrB2  Dihydrofolate reductase  Tp  AS, EW  
dfrD  Dihydrofolate reductase  Tp  AS, EW  
dhfr1  Dihydrofolate reductase  Tp  AS, EW  
dhfrVIII  Dihydrofolate reductase  Tp  AS, EW  
dhfrXV  Dihydrofolate reductase  Tp  AS, EW  
tetA  MFS tetracycline efflux  Tc  AS, EW, DW, 
EW, NW, SD, 
SW, US 
tetA  MFS tetracycline efflux  Tc  AS, EW  
tetA  MFS tetracycline efflux  Tc  AS, EW  
tetA  MFS tetracycline efflux  Tc  AS, EW  
tetA (41)  MFS tetracycline efflux  Tc  NW 
tetB MFS tetracycline efflux  Tc  AS, DW, EW, 
NW, SW, US 
tetC MFS tetracycline efflux  Tc  AS, EW, SW, US 
tetD  MFS tetracycline efflux  Tc  AS, EW, DW, 
EW, SW, US 
tetE MFS tetracycline efflux  Tc  AS, EW, SD, SW, 
US 
tetG  MFS tetracycline efflux  Tc  AS, EW, SW, US 
tetH  MFS tetracycline efflux  Tc  AS, EW, SW 
tetJ MFS tetracycline efflux  Tc  SW 
tetL  MFS tetracycline efflux  Tc  AS  
tet(U)  Replication  Low level Tc  AS, EW  
tetY  MFS tetracycline efflux  Tc  AS, EW, SW 
tetZ MFS tetracycline efflux  Tc  SW 
tet33 MFS tetracycline efflux  Tc  SW 
otrB MFS tetracycline efflux  Tc  AS, NW, SW 
tetR(31)  Tetracycline repressor protein  Regulates 
expression of 
AS, EW  
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Gene name*  Gene product  Resistance to Detected in water 
environments 
TetA(31) 
effJ (tet(35))  Putative tetracycline efflux pump  Tc  EW  
tet(39)  MFS tetracycline efflux  Tc  AS, EW, SD, SW 
tetB(P)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, SD, SW 
tet(M)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, EW, NW, SD, 
SW, US 
tet(M)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, EW 
tet(M)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, EW  
tet(M)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, EW  
tet(O)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, EW, NW, SD, 
SW, US 
tet(Q)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, EW, NW, 
SW, US 
tet(S)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, EW, NW, 
SW, US 
tet(T)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  SD, SW 
tet(W)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  SD, NW, SW 
otrA GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS, NW, SW 
tet(32)  GTP-binding elongation factor protein, 
TetM/TetO family   
Tc  AS  
tet(36)  Ribosomal protection tetracycline 
resistance protein  
Tc  EW 
tet(X)  Inactivation of tetracycline  Tc  AS, EW 
qacB  Permease of the MFS family, multidrug 
efflux protein  
Multidrug efflux  AS 
qacED1  Small multidrug resistance protein, 
membrane transporter of cations and 
cationic drugs  
QAC  AS, EW 
qacF  Small multidrug resistance protein, 
membrane transporter of cations and 
cationic drugs  
QAC  AS 
qacF, qacH  Small multidrug resistance protein, 
membrane transporter of cations and 
cationic drugs  
QAC  AS, EW 
qacG2  Small multidrug resistance protein, 
membrane transporter of cations and 
cationic drugs  
QAC  AS, EW 
acrB  RND family, acridine/multidrug efflux 
pump  
Multidrug efflux  AS, EW 
acrD  Cation/multidrug efflux pump  Aminoglycosides
, Nv  
AS, EW 
mexB  Cation/multidrug efflux pump, RND 
multidrug efflux transporter  
Multidrug efflux  AS, EW 
mexD  RND multidrug efflux transporter  Em, Rox  AS, EW 
mexD  Cation/multidrug efflux pump, RND 
multidrug efflux transporter  
Multidrug efflux  AS, EW 
mexF  Cation/multidrug efflux pump, RND 
multidrug efflux transporter  
Multidrug efflux  AS, EW 
mexI  Cation/multidrug efflux pump, RND Multidrug efflux  AS, EW 
 41 
 
Gene name*  Gene product  Resistance to Detected in water 
environments 
multidrug efflux transporter  
mexY  Cation/multidrug efflux pump, RND 
multidrug efflux transporter  
Multidrug efflux  AS, EW 
orf11  ABC type permease  Nal, Nor  AS, EW 
kikA  Killing in Klebsiella  IncN-specific 
gene  
AS, EW 
oriV  Origin of vegetative replication  IncW-specific 
region  
 EW 
oriV  Origin of vegetative replication  IncQ-specific 
region  
AS, EW 
rep  Replication initiation protein  IncA/C-specific 
gene  
AS, EW 
repE  Replication initiation protein  IncFIA-specific 
replication gene  
AS, EW 
trfA  Replication initiation protein  Initiation of 
replication, IncP-
specific gene  
AS, EW 
a Summarized from the references (Szczepanowski et al., 2009; Zhang et al., 2009) 
*Resistance genes recently described in clinical isolates. 
Abbreviations: Ak, amikacin; Amo, amoxicillin; Amp, ampicillin; Atm, 
aztreonam; Azm, azithromycin; Car, carbenicillin; Caz, ceftazidim; Cec, cefaclor; 
Cfp, cefoperazon; Cft, ceftibuten; Cip, ciprofloxacin; Clr, clarithromycin; Cm, 
chloramphenicol; Cpo, cefpirom; Cro, ceftriaxon; Ctx, 
cefotaxime; Cxm, cefuroxime; Em, erythromycin; Fep, cefepim; Ffc, florfenicol; 
Fox, cefoxitin; Gm, gentamicin; Ipm, imipenem; Kf,  cephalothin; Km, 
kanamycin; Lev, levofloxacin; Met, meticillin; MLS, macrolide-lincosamide-
streptogramin B; Mez, mezlocillin; Nal, nalidixic acid; Neo, neomycin; Nor, 
norfloxacin; Nv, novobiocin; Ob, cloxacillin; Ofx, ofloxacin; Pen-G, penicillin G; 
Prl, piperacillin; QAC, quaternary ammonium compounds; Rif, rifampicin; Rox, 
roxithromycin; Spar, sparfloxacin; Sm, streptomycin; Sp, spectinomycin ; Sul, 
sulfonamides; Tc, tetracyclines; Tic, ticarcillin; Tob, tobramycin; Tp, 
trimethoprim; Ty, tylosin.  
The antibiotic resistance genes were detected in the following water environments: 
SW special wastewater from hospital, animal production, and aquaculture area; 
US untreated sewage; AS activated sludge of sewage treatment plant; EW effluent 




2.5     Concluding remarks 
Due to the massive production and improper usage of antibiotics since 
1940s, large numbers of antibiotic resistance genes have been developed and 
distributed in the biosphere microorganisms, which has overwhelmed the 
therapeutic usage of antibiotics used today.  However, limited knowledge on the 
roles of antibiotics and antibiotic resistance in nature has hampered the efforts to 
prevent and control the antibiotic resistance.  It is recently updated that the sub-
inhibitory concentrations of antibiotics may play a universal signaling role to 
select adaptive phenotypic and genotypic microbes in various ecosystems.  
Nevertheless, the causal relationship between the low concentrations of antibiotics 
detected in the environment and the proliferation of antibiotic resistance genes is 
not identified yet, neither the effects of the sub-inhibitory concentrations of 
antibiotics on the ecological function disturbance and on the selection of resistant 
microorganisms in the environment.  Therefore, it would be essential to 
investigate the impacts of low concentrations of antibiotics (e.g. erythromycin) on 
the micro-ecology of WWTPs, which are the main reservoirs of the antibiotics 






Chapter 3      
Influence of Trace ERY and ERY-H2O on Carbon and 
Nutrient Removal and on Resistance Selection in SBRs 
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3.1     Abstract 
Three SBRs were operated in parallel to study the effects of trace ERY and 
ERY-H2O on the treatment of a synthetic wastewater.  Through monitoring (1) daily 
effluents and (2) concentrations of N and P in certain batch cycles of the three 
reactors operated from transient to steady states, the removal of carbon, N, and P was 
affected negligibly by ERY (100 µg/L) or ERY-H2O (50 µg/L) when compared with 
the control reactor.  However, through analyzing microbial communities of the three 
steady state SBRs on high-density microarrays (PhyloChip), ERY, and ERY-H2O had 
pronounced effects on the community composition of bacteria related to N and P 
removal, leading to diversity loss and abundance change.  The above observations 
indicated that resistant bacteria were selected upon exposure to ERY or ERY-H2O.  
Short-term batch experiments further proved the resistance and demonstrated that 
ammonium oxidation (56–95%) was inhibited more significantly than nitrite 
oxidation (18–61%) in the presence of ERY (100, 400, or 800 µg/L).  Therefore, the 
presence of ERY or ERY-H2O (at µg/L levels) shifted the microbial community and 
selected resistant bacteria, which may counteract the influence of the antibiotic ERY 
or its derivative ERY-H2O (at µg/L levels) on carbon, N, and P removal in the SBRs. 
 
3.2     Introduction 
Macrolide antibiotics are among the most important and common antibacterial 
agents applied to both human and animal diseases caused by bacteria (Dubois et al., 
2001; Pothuluri et al., 1998).  Macrolides prevent bacterial growth by binding to the 
23S ribosomal RNA (rRNA) of the large (50S) ribosomal subunit so as to inhibit 
protein synthesis in the elongation step (Verdier et al., 2001).  Though macrolides can 
be metabolized by demethylation in the body, the urinary excretion of unchanged 
  45 
parent drugs could reach 5–10% for ERY, 10–20% for clarithromycin, 30% for 
roxithromycin, 10–20% for spiramycin, and 6–12% for azithromycin (Forth et al., 
1992).  Unlike other macrolide members, ERY can be inactivated easily by gastric 
acid to form ERY-H2O by losing one molecule of water (McArdell et al., 2003).  
Although ERY-H2O has negligible antibacterial activity, it may be involved in 
inducing bacterial resistance to the parent drug (Majer, 1981).  The excreted urine, 
carrying the active antibiotics and their metabolites, will be finally discharged to the 
wastewater treatment systems. 
In contrast to the macrolide antibiotics working principle, mechanisms of 
bacterial resistance can be the excretion of antibiotic drugs by efflux pumps or the 
alteration of the target site to avoid binding of these drugs (Amin et al., 2006).  To 
gain resistance, bacteria can also destruct or modify the macrolides directly by the 
enzymatic hydrolysis (macrolide esterase) and group transfer strategies (phosphate 
transfer and glycosyltransfer) (Wright, 2005).  Therefore, the massive use of the 
macrolide antibiotics has raised questions on the possible long-term consequences of 
resistance selection because trace levels of macrolides have been detected in aquatic 
environments (Giger et al., 2003; Hirsch et al., 1999; Karthikeyan and Meyer, 2006; 
Kolpin et al., 2002; McArdell et al., 2003; Richardson et al., 2005; Xu et al., 2007b).  
As one of the macrolide antibiotics, ERY was measured as ERY-H2O in most studies 
because ERY could be transformed to ERY-H2O in the slightly acidic aquatic 
environment or during the solid phase extraction at acidic conditions.  Dehydrated 
erythromycin has been detected in most of water or wastewater samples surveyed 
worldwide, such as America (Karthikeyan and Meyer, 2006; Kolpin et al., 2002), 
Canada (Miao et al., 2004), Germany (Hirsch et al., 1999), Switzerland (Giger et al., 
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2003; McArdell et al., 2003), Taiwan (Lin and Tsai, 2009), Hong Kong (Gulkowska 
et al., 2008), and China (Richardson et al., 2005; Xu et al., 2007b).   
It was speculated that the ERY-resistant pathogenic bacteria could be 
developed even at low ERY concentrations (less than 2 µg/L) in WWTPs, which 
breed a much wider range of environmental bacteria than the natural aquatic 
environment (Hirsch et al., 1999).  Although the potential effects of ERY, at ultra-low 
concentrations (µg/L), on WWTPs have attracted the attention from the public and 
scientific communities, few investigations have been made so far.  Most studies have 
been conducted on the detection of ERY-H2O at low concentrations in the WWTPs 
(Giger et al., 2003; Hirsch et al., 1999; Karthikeyan and Meyer, 2006; McArdell et al., 
2003).  Usually, the resistance or susceptibility of cultures to ERY is judged by 
inhibitory concentrations.  For example, it is reported that the inhibitory 
concentrations of ERY to selected pure cultures were 0.01–10 mg/L and 0.1–>200 
mg/L to the Gram-positive and Gram-negative organisms, respectively (Oleinick, 
1975).  Nimenya (1999) concluded the highly significant linear correlation between 
dose of ERY (10, 20, 40, and 80 mg/L) and its inhibition on ammonia removal 
(correlation coefficient r=0.890, probability value p<0.05) and nitrate production 
(r=0.937, p<0.05), in which the reported inhibition percentage of ammonium 
oxidation and nitrate production was 0.20% and 0.28% at ERY of 1 mg/L.  
Additionally, the influence of ERY at relatively high concentrations in the 
pharmaceutical wastewater was studied in anaerobic reactors.  For example, Amin 
(2006) suggested that the development of antibiotic resistance alleviated the inhibition 
of ERY (1–200 mg/L) on biogas production and on butyric acid conversion in an 
anaerobic lab scale reactor with complex microbial communities, accompanying with 
concentrations of ERY in the effluent ranging from 0.4–150 mg/L.  In order to reach 
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the discharge standard of chemical oxygen demand (COD), effluent of anaerobic 
processes is always treated by aerobic processes, in which ERY might be further 
removed.   
The aim of this study was to assess the influence of ERY or ERY-H2O at low 
concentrations (µg/L) on the carbon, nitrogen, and phosphorous removal in SBRs.  
The inhibitory effects on carbon and nutrients removal were evaluated by a long-term 
operation of three SBRs, namely R1, R2, and R3 fed with the same synthetic 
wastewater but spiked with 50 µg/L of ERY-H2O, 100 µg/L of ERY and no 
antibiotics, respectively.  The microbial communities of the three steady state SBRs 
were analyzed by employing high-density phylogenic 16S rRNA gene microarrays 
(PhyloChip) containing 1,440 distinguishable prokaryotic operational taxonomic units 
(OTUs), and the community shifts in R1 (ERY-H2O) and R2 (ERY) were compared 
with that in R3 (control).  To verify whether the PhyloChip-observed nitrifying 
bacteria shifts were correlated with their resistance to ERY, short-term running batch 
experiments were conducted to study higher concentrations (100, 400, and 800 µg/L) 
of ERY’s inhibition on nitrifying bacteria present in the biomass of the three steady 
state SBRs.    
3.3     Materials and methods 
3.3.1    Startup and operation of SBRs 
Three SBRs (4 L) were started up with the same seeding sludge from a mother 
reactor (MR).  The MR was seeded with sludge collected from an aeration tank of a 
local domestic WWTP.  Before being inoculated to the three SBRs, the sludge in MR 
was fed with synthetic wastewater for 8 months to minimize the residue inhibitory 
and resistant effects of antibiotics possibly existing in the local domestic wastewater, 
as well as, to achieve optimal nitrogen and phosphorus removal by adjusting 
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operation parameters, such as solids retention time (SRT), hydraulic retention time 
(HRT), aeration, and batch modes.   
The synthetic wastewater consisted of total organic carbon (TOC) of 225 mg/L 
(equal to theoretical COD of 600 mg/L) from glucose of 563 mg/L, NH4+–N of 60 
mg/L from NH4Cl of 229 mg/L, PO43-–P of 15 mg/L from K2HPO4 of 84 mg/L, 
alkalinity of 420 mg/L from NaHCO3 of 706 mg/L, and the trace elements in mg/L 
(EDTA 3; Na2MoO4.2H2O 1.23; CaSO4.2H2O 24.6; MgSO4 6; CoCl2.6H2O 4; 
FeCl3.H2O 15; CuSO4.5H2O 0.002; MnSO4.H2O 0.16; ZnSO4.7H2O 0.002; KI 0.002; 
and H3BO3 0.002).  The MR was fed with synthetic wastewater in half-concentration 
all the time, while the three SBRs were fed with the synthetic wastewater in half-
concentration only during the first 34 days to model the wastewater at relative low 
concentrations, and then increased to full concentration from day 35 to represent the 
wastewater at relative high concentrations.  During the entire operation, the SBRs 
were spiked with ERY-H2O of 50 µg/L (R1), ERY of 100 µg/L (R2), and no 
antibiotics (R3), respectively. The concentrations of ERY and ERY-H2O in this study 
are all in the µg/L range, which can be found in the effluent of plants treating 
pharmaceutical wastewater or in the hospital effluents. The reason to choose relatively 
higher concentration of ERY (100µg/L) than ERY-H2O (50µg/L) is that ERY could 
be degraded to ERY-H2O at slightly acidic conditions. By adding a little more ERY, 
the microbes in the reactors are always exposed to it though some degradation may 
occur under unpleasant conditions.  From day 56 to 62, the wasted sludge collected 
from R2 (ERY) was used to set up a fourth reactor R2’.  The R2’ (fed with ERY of 
100 µg/L) was operated as the same as R2 except that it was applied with a shock 
loading of high TOC up to 6,000 mg/L on day 66, which commonly encountered in 
pharmaceutical wastewater treatment plants (Amin et al., 2006; Yang et al., 2009), 
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following by various TOC loading until day 130.  The TOC and nitrogen contributed 
by ERY-H2O or ERY were negligible (about 0.6 g TOC and 0.02 g N/g ERY or ERY-
H2O).  Erythromycin (potency≥850 µg/mg) and all other chemicals were supplied by 
Sigma-Aldrich (Singapore).  Erythromycin stock solution was prepared in 2mM 
NaHCO3 (pH=7.3) because its degradation rate increases logarithmically with a 
decrease of pH from 7.3 to 3.5 (Kim et al., 2004).  Dehydrated erythromycin was 
prepared according to the previously reported method (Abuin et al., 2006; McArdell 
et al., 2003).   
With an accurate programmable logic controller, the three SBRs were operated 
simultaneously in the same batch mode of an 8-hour cycle, consisting of inlet (0–14 
min), pre-mixing for anoxic/anaerobic condition (0–60 min), aeration for oxic 
condition (60–300 min), post-mixing for anoxic condition (300–364 min), waste 
sludge (360–364 min) by decanting ~1/20 volume of 4 L mixed liquid (SRT 6.7 days, 
which is derived by 20/3 and 3 means three cycles per day), settling (364–404min), 
decanting supernatant to 2 L (404–440min; HRT 16 hr) and idle (440–480min) (Fig. 
3.1).  The dilution factor was 2 for the three SBRs by discharging 2 L of liquid from 
the 4 L reactor in each cycle.  The pH ranged from 6.6 to 8.2 during one cycle without 
adjustment.  The stable oxygen supply during aeration guaranteed ~ 5 mg/L of 
dissolved oxygen (DO) at the end of aeration phase except for R2’ (ERY) during the 
shock load period.  All SBRs were operated under ambient temperature (25–27°C). 
 
Fig. 3.1 Batch mode of sequencing batch reactors (SBRs).  
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3.3.2    Batch experiments 
To test the long-term resistance selection of nitrifying bacteria exposed to 
ERY-H2O (50 µg/L) in R1 and ERY (100 µg/L) in R2, short-term batch experiments 
of ammonium oxidation and nitrite oxidation were performed in 250 ml flask bottles 
with a shaking speed of 150 rpm.  The ammonium oxidation batches were conducted 
in thirty-six flasks, which were filled with 50 ml of diluted ATCC medium 2,265 
(Nitrosomonas europaea medium) to a final concentration of 35 mg/L NH4+–N except 
replacing Na2CO3 with NaHCO3 of 490 mg/L.  The thirty-six flasks were divided into 
three groups for inocula from R1 (ERY-H2O), R2 (ERY), and R3 (control), 
respectively.  Then each group of twelve flasks was spiked with ERY at 
concentrations of 0 (control), 100, 400, and 800 µg/L in triplicates.  The nitrite 
oxidation batches were conducted in the same way as the ammonium oxidation 
batches in another thirty-six flasks, but filled with 50 ml of diluted ATCC medium 
480 (Nitrobacter medium 203) to a final concentration of 21 mg/L NO2-–N.  Similarly 
to the above experiments on ERY, ammonium oxidation and nitrite oxidation were 
conducted on inocula from R1, R2, and R3 in a total of seventy-two flasks spiked 
with ERY-H2O at concentrations of 0 (control), 100, 400, and 800 µg/L.  The inocula, 
1ml of biomass taken from the steady state SBRs, were washed three times with the 
aforementioned media by centrifugation to minimize previously fed antibiotics and 
organic carbon, and then were added to the liquid medium (2% by volume of inocula).  
All inocula were freshly applied in only one batch of experiments to avoid artificially 
selecting for primarily resistant organisms.  The flask bottles were placed on a shaker 
for mixing and aeration at room temperature (25–27°C).    
Statistical analysis of the biomass-source dependent ERY inhibition was 
carried out by the simple paired Student’s t test to compare the daily product 
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concentrations between any two of the three sources biomass during the 3-day period 
of the batch experiments.  Differences were considered significant if the probability 
values p≤0.05. 
 
3.3.3    Collection and preparation of samples 
During the operation of the three SBRs, equal volumes (5 ml) of effluents 
from three cycles of each day were collected, and then mixed together as the daily 
effluent for analysis.  Samples in SBRs within one cycle were collected according to 
online DO and pH signals, which were the indicators for carbon and nitrogen removal 
(Yang et al., 2007).  The frequency of cycle analysis was once for every 3 to 5 days in 
the transient and the early steady states and decreased to every 7 to 30 days in the 
later steady states.  Samples from SBRs were filtered through a sterile filter 
membrane (GN-6 Metricel S-Pack, 0.45 µm, 47mm, mixed cellulose ester, Pall Cop., 
USA) for TOC, nitrification, and phosphate removal analysis.  Therefore, the 
measured TOC, phosphate, and all kinds of nitrogen were in dissolved forms 
throughout this study.  To avoid sorption on membrane during filtration, the samples 
for antibiotics analysis were centrifuged at 14,000 rpm for 15 min at 25°C.   Samples 
from batch conical flasks were collected daily and centrifuged as above.   
 
3.3.4    Analytical methods  
The concentrations of dissolved TOC and dissolved TN were detected on a 
TOC analyzer with a TN measuring unit (Shimadzu TOC-Vcsh combined with TNM-
1 Unit, Japan).  Measurement of the dissolved phosphorus (PO43-–P) and nitrogen in 
forms of NO3-–N, NO2-–N and NH4+–N were performed on an ion chromatography 
(DIONEX DX500 chromatography system, USA).  Erythromycin and ERY-H2O were 
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analyzed on a high performance liquid chromatography (Agilent 1100 Series, Agilent 
Technologies, Germany) with electro-spray tandem mass spectrometry (API 2000TM, 
Applied Biosystems/MDS Sciex, USA; LC-MS-MS).  The previously reported LC 
method (McArdell et al., 2003) was utilized for analysis of ERY and ERY-H2O on a 
reverse phase XbridgeTM Phenyl column (50 ×2.1 mm id, 3.5μm, waters Inc., USA.) 
protected by a guard column (XbridgeTM Phenyl, 10 ×2.1 mm id, 3.5μm, waters Inc., 
USA.).  The MS-MS analysis was performed in the positive ion mode (McArdell et 
al., 2003).  One precursor ion and one product ion were chosen for MS-MS 
determination, that is, m/z 734.5 and 158.2 for ERY and m/z 716.5 and 158.2 for 
ERY-H2O.  The detection limits were 10 µg/L for ERY and 8 µg/L for ERY-H2O.     
 
3.3.5    DNA extraction, polymerase chain reaction and PhyloChip   
Approximately 1 ml of mixed liquid was centrifuged (14,000 g, 5 min) and 
cell pellets were collected for DNA extraction.  The genomic DNA was extracted and 
purified by using DNeasy Tissue Kit (QIAGEN GmbH, Germany), except with 
modification of bead beating the cells with glass beads (Diameter 0.1mm, Biospec, 
USA) for better cell lysis.  The high-density phylogenic 16S rRNA gene microarrays 
(PhyloChip) employed in this study contain 1,440 distinguishable prokaryotic OTUs 
identified by 35,000 probes, which were designed according to the approach 
described previously  (DeSantis et al., 2003).  Each DNA pool extracted from 
triplicate sludge samples was tested on triplicate PhyloChips.  The 16S rRNA gene 
amplification, PhyloChip processing, scanning, OTU scoring, and normalization were 
all performed as previously described (Brodie et al., 2006; Flanagan et al., 2007).   
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3.4     Results  
3.4.1    Effects of ERY-H2O on SBR performance 
The sequencing batch reactor R1 (fed with 50 µg/L of ERY-H2O) and R3 
(control reactor) reached their first steady state (e.g., constant carbon and nutrients 
removal) on day 21 when added with TOC of 110 mg/L, NH4+–N of 30 mg/L and 
PO43-–P of 7.5 mg/L.  After doubling the concentrations of TOC, NH4+–N and PO43-–
P on day 35, R1 (ERY-H2O) and R3 (control) once again reached their steady states 
after day 55.  Similar carbon and nitrogen removal profiles were observed in R1 
(ERY-H2O) and R3 (control) during the whole running period of 400 days (Fig. 3.2 
showed data of 180 days, and Fig. 3.3 showed data of 400 days), which were 
consistent with the intensive observation on nitrogen removal profile within 
individual cycle during the steady states (Fig. 3.4).  Concentrations of TOC in 
effluents of R1 (ERY-H2O) and R3 (control) were below 10 mg/L in most of the days 
during the operation period, even with doubled concentrations of influent on day 35.  
The NH4+–N concentrations were undetected in the daily effluents for most of the 
days, indicating that ammonium oxidation was completed and not affected by the 
increased dosage of both TOC and NH4+–N in the influents on day 35.  As the 
intermediate of nitrification and denitrification, NO2-–N was not accumulated in the 
effluents and appeared to be negligible during the aerobic nitrification process.  
Because the amount of TN and NO3-–N decreased in the post-mixing period (Fig. 
3.4), endogenous denitrification occurred.  Additionally, ERY-H2O concentration in 
the effluent of R1 (ERY-H2O) was always ~ 15 µg/L.  The missed 70% of ERY-H2O 
(~ 35 µg/L) could be adsorbed to the sludge or degraded by the biomass.   
 
  54 
3.4.2    Effects of ERY on SBR performance  
Similarly, when comparing the TOC and NH4+–N removal of R2 (100 µg/L of 
ERY) with that of R3 (control), ERY was not found to have any effect on the 
performance of the reactor during the 400 days operation (Fig. 3.2 and Fig. 3.3). To 
further understand whether the antibiotic ERY at µg/L levels could cause the 
performance of reactor beyond recovery at accidental conditions (such as the 
commonly occurred shock loading of high TOC in pharmaceutical wastewater 
treatment plants), a TOC of 6,000 mg/L in the influent was supplied to R2’ (a 
duplicate of R2) for 1 week (from day 65 to 72), while R2 (ERY) was operated at 
normal TOC concentration of 220 mg/L to avoid reactor failure and to minimize 
possible microbial community changes due to the TOC shock.  The results showed 
that carbon removal in R2’ (ERY) was recovered within 18 days after the shock of 
high TOC, indicating that ERY did not prevent R2’ from recovery, though the 
nutrients of nitrogen (N) and phosphorous (P) were insufficient (Fig. 3.2b’ and Fig. 
3.3b).  The following describes the recovery process.  When the concentration of TOC 
in the influent was reduced to 400 mg/L (from day 73 to 90), the concentration of 
TOC in the effluent decreased in four levels (3,500 mg/L, 400 mg/L, 200 mg/L and 
then lower than 50 mg/L on day 82), indicating that the organic carbon was 
biodegraded rather than by dilution because of a dilution factor of only 2 for the 
SBRs.  After day 91, with enough aeration and overdosed nutrient, carbon removal in 
R2’ (ERY) was recovered totally as TOC concentrations in the effluent dropped to 15 
mg/L and maintained below 10 mg/L in later days.   
Moreover, during the periods of the shock loading and the recovery phases of 
R2’ (ERY), the results demonstrated typical profiles of nitrification, from nitrite 
production to complete nitrification (Fig. 3.2e and Fig. 3.3e).  The change occurs 
  55 
commonly when SBRs start nitrification even without antibiotics, since ammonium 
oxidizing microorganisms (AOMs; like Nitrosomonas) grow significantly faster than  
nitrite oxidizing bacteria (NOB; like Nitrospira) (Watson et al., 1989).  When R2’ 
(ERY) was fed with excess amount of ammonium than assimilation required on day 
91, the NO2-–N and NO3-–N appeared in the effluent with the decrease of NH4+–N 
from day 100, indicating that nitrification resumed.  The reduction of TN observed 
from day 100 to day 110 suggests that denitrification resumed from day 100 as well, 
and reached an equilibrium from day 110 in R2’ (ERY).  Interestingly, the 
intermediate NO2-–N appeared to be a dominant nitrogen product from day 100 to day 
106, which was taken over by NO3-–N as usual after day 106.  The transit of 
nitrification processes was clearly confirmed by the accumulation of NO2-–N in the 
aeration period as observed within the cycles on day 119, while not in cycles on day 
130 (Fig. 3.4).  
Additionally, during the whole operation period, the concentrations of ERY in 
the effluent of R2 (ERY) were below the detection limit (10 µg/L), and ERY-H2O 
which could be produced from ERY was not detected in most of the days either 
(detection limit of 8 µg/L).  Therefore, the missed ERY might be attributed by the 
sorption to the biomass in R2 (ERY) or degradation to compounds other than ERY-
H2O. 
 
  56 
(a)  ● R1( ERY-H2O)
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Fig. 3.2  180-day daily effluents of R1 (ERY-H2O of 50 µg/L), R2 or R2’ (ERY of 
100 µg/L), and R3 (control): the averages of soluble TOC (●) or (○) in daily effluents 
consist of equal volumes of effluents from three cycles of each day 
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Continued Fig. 3.2  180-day daily effluents of R1 (ERY-H2O of 50 µg/L) and R3 
(control): the averages of soluble TN (▲), NO3-–N (■), NO2-–N (×), and NH4+–N (◆) 
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Continued Fig. 3.2  180-day daily effluents of R2 or R2’ (ERY of 100 µg/L): the 
averages of soluble TN (▲), NO3-–N (■), NO2-–N (×), and NH4+–N (◆) in daily 
effluents consist of equal volumes of effluents from three cycles of each day 
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Fig. 3.3  400-day daily effluents of R1 (ERY-H2O of 50 µg/L) and R3 (control): the averages of soluble TOC (●) or (○) in daily effluents consist 
of equal volumes of effluents from three cycles of each day 
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Continued Fig. 3.3  400-day daily effluents of R2 or R2’ (ERY of 100 µg/l),: the averages of soluble TOC (●) in daily effluents consist of equal 
volumes of effluents from three cycles of each day 
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Continued Fig. 3.3  400-day daily effluents of R1 (ERY-H2O of 50 µg/L): the averages of soluble TN (▲), NO3-–N (■), NO2-–N (×), and 
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Continued Fig. 3.3  400-day daily effluents of R3 (control): the averages of soluble TN (▲), NO3-–N (■), NO2-–N (×), and NH4+–N (◆) in daily 
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Continued Fig. 3.3  400-day daily effluents of R2 or R2’ (ERY of 100 µg/l): the averages of soluble TN (▲), NO3-–N (■), NO2-–N (×), and 




























Fig. 3.4  Comparison of nitrogen dynamics within the cycles of a R1 (ERY-H2O) and 
b R3 (control) during the steady states: soluble TN (▲), NO3-–N (■), NO2-–N (×) and 
NH4+–N (◆)  
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Continued Fig. 3.4  Comparison of nitrogen dynamics within the cycles of c R2’ 
(ERY) on day 119, and d R2’ (ERY) on day 130: soluble TN (▲), NO3-–N (■), NO2-
–N (×) and NH4+–N (◆) 
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3.4.3    Phosphorus removal affected by ERY and ERY-H2O 
Since phosphorus removal is another key parameter to evaluate the 
performance of the reactors, average concentrations of PO43-–P were monitored in the 
daily effluents of the three SBRs (Fig. 3.5).  The averages of PO43-–P during the 400 
days operation were 3.7, 4.6, and 4.8 mg/L for R1 (ERY-H2O), R2 (ERY), and R3 
(control), respectively.  To capture detailed process dynamics for PO43-–P 
concentrations, 8-hour cycles were investigated for all three SBRs in the steady states.  
In all the cycles investigated, the PO43-–P release in R1 (ERY-H2O) during the 60-
minute of premixing period was relatively more than that in R2 (ERY) and R3 
(control) (Fig. 3.5).  The subtle lower PO43-–P concentrations in effluent of R1 (ERY-
H2O) than those in R2 (ERY) and R3 (control) might be due to the higher PO43-–P 
release in R1 (ERY-H2O) than those in other two reactors.   
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Fig. 3.5  a The averages of soluble PO43-–P in the daily effluents of R1 (ERY-H2O), R2 (ERY), and R3 (control).: soluble PO43-–P of R1 (▲), 
R2 (□), and R3 (●)  



















Continued Fig. 3.5 b Comparison of phosphorus dynamics within the cycles of R1, 
R2, and R3 on day 160 during the steady states: soluble PO43-–P of R1 (▲), R2 (□), 
and R3 (●) 
 
3.4.4    PhyloChip-analyzed changes of microorganisms related to phosphorus 
and nitrogen removal  
To further understand the slightly improved PO43-–P removal in R1, genomic 
DNA extracted from steady state R1, R2, and R3 on day 367 was analyzed on the 
PhyloChips with probes that target the OTUs of Rhodocyclus-related poly-P 
accumulating organisms (PAOs) under the family of Rhodocyclacea and target the 
OTUs of glycogen accumulating organisms (GAOs, competing with PAOs for carbon 
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source) under the order of GAO cluster, respectively.  With PAOs and GAOs in R3 as 
the control, results showed that the PAOs fluorescence intensity decreased and the 
GAOs intensity increased slightly in R1 (ERY-H2O); both intensities of PAOs and 
GAOs in R2 (ERY) increased (Fig. 3.6).  Also, the diversity of PAOs was lost in both 
R1 and R2 when comparing with that of R3 (Table 3.1).  Therefore, ERY or ERY-
H2O changed phosphorus removal populations, which had potential impact on the 
phosphorus concentrations in the effluent.  Moreover, due to limited OTUs related to 
PAOs and GAOs on the PhyloChip, the increase of GAOs intensity in R1 and R2 
could not indicate the enhancement of GAOs by ERY or ERY-H2O; similarly, the 
decrease of PAOs diversity and intensity in R1 might not represent the actual resistant 
PAOs selected by ERY-H2O.  The data are not enough to explain the phenomena of 
the slightly improved phosphorus removal in R1 (than R2 and R3). 
In addition to phosphorus removal bacteria, nitrifying bacteria is another key 
group of organisms in wastewater treatment processes.  The probes on the PhyloChip 
cover most of the nitrifying bacteria existing in WWTPs, including the AOMs under 
the family of Nitrosomonadaceae (including Nitrosomonas, Nitrosospira) and 
Chromatiaceae (Nitrosococcus oceani), the NOBs under the family of 
Bradyrhizobiaceae (Nitrobacter) and Nitrospiraceae (Nitrospira), and the anammox 
bacteria (strictly anaerobic bacteria occupying minor population in SBRs with aerobic 
conditions) under the family of Anammoxales, Pirellulae, and Planctomycetaceae.  
All these nitrifying bacteria studied are known as Gram-negative.  Comparing with 
those in R3 (control), the fluorescence intensity of AOMs and NOBs decreased 
significantly in R1 (ERY-H2O) and R2 (ERY), but anammox bacteria increased 
slightly in R1 and R2 (Fig. 3.6).  The PhyloChip data also demonstrated taxa diversity 
reduction for nitrifying bacteria in R1 (50 µg/L of ERY-H2O) and R2 (100 µg/L of 
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ERY) comparing with R3 (control; Table 3.1).  The observed taxa diversity loss was 
the most for Nitrosomonadaceae (the dominant AOMs in WWTPs) in R1 of 80% and 
in R2 of 70%.  The existing OTUs of Nitrosomonadaceae in R1 and R2 had the 
higher specific intensity than those in R3, suggesting that the less diverse AOMs 
selected by ERY-H2O or ERY could play the same role as the more diverse 
community in R3.  Indeed, ammonium oxidation was similar in the three SBRs as 
shown in Fig. 3.2, Fig 3.3 and Fig. 3.4. Similarly, nitrifying bacteria (AOMs and 
NOBs) with the same nitrification performance (Fig. 3.2, Fig. 3.3 and Fig. 3.4) but the 
lower diversity and total intensity in R1 and R2 than those in R3 (Table 3.1 and Fig. 
3.6) may have a higher specific nitrification capacity which suggests a higher 
antibiotic resistance.  For instance, the total intensity of AOMs on the PhyloChip 
showed a trend of R1 (ERY-H2O)<R2 (ERY)<R3 (control), indicating that the 
specific ammonium oxidizing capacity and antibiotic resistance of AOMs were in a 
reverse order of R1 (ERY-H2O)>R2 (ERY)>R3 (control).  Similarly, the total 
intensity of NOBs demonstrated a trend of R2 (ERY)<R1 (ERY-H2O)<R3 (control), 
indicating that the specific nitrite oxidizing capacity and antibiotic resistance of NOBs 
could be R2 (ERY)>R1 (ERY-H2O)>R3 (control).   
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Fig. 3.6  PhyloChip analysis of microorganism populations related to nitrification and 
biological P removal in three steady state SBRs. Bars above the zero line represent 
bacteria that increased in abundance relative to R3; bars below represent those 
bacteria that declined in abundance 
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Table 3.1  PhyloChip analysis of microorganism diversity related to nitrification and biological P removal in three steady-state SBRs  
Relative to R3, common OTUs in R1 and R2 (R12); R1 and R3 (R13); R2 and R3 (R23); and R1, R2, and R3 (R123) 
 OTU richness relative to R3 (%) Common OTUs relative to R3 (%) 
  R1 R2 R12 R13 R23 R123 
AOMs-Nitrosomonadaceae (Nitrosomonas, Nitrosospira) 20  30  20 20 20 20 
AOMs-Chromatiaceae (Nitrosococcus oceani) 71  57  43  71  57  43  
NOBs-Bradyrhizobiaceae (Nitrobacter) 86  91  86  86  91  86  
NOBs-Nitrospiraceae (Nitrospira) 50  100  50  50  100  50  
Anammox bacteria 89  78  78  89  78  78  
GAOs 100  133  100  100  100  100  
PAOs 73  80  53  53  73  53  
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3.4.5    Resistance selection of nitrifying bacteria upon exposure to ERY or ERY-
H2O 
To verify the resistance selection of nitrifying bacteria indicated by 
PhyloChip-observed shifts in AOMs and NOBs, biomass from the three steady state 
SBRs on day 390 were inoculated to the conical flasks with organic carbon free media 
spiked with different dosages of ERY or ERY-H2O.  The impact of biomass growth 
on the batch experiments can be ignored, since the optical densities of mixing liquid 
in the flasks showed no difference with time in the 3-day batch experiments.  The 
negligible growth of the biomass can be explained by that fast growing heterotrophic 
bacteria cannot be supported by these organic carbon free media and the autotrophic 
nitrifying bacteria (usually occupy 2–3% of total activated sludge biomass) possess 
relatively long doubling time (such as >8 h at optimal conditions) (Koch et al., 2001; 
Prosser, 1989).  In the flasks spiked with ERY-H2O (at concentrations of 100, 400, 
and 800 µg/L), the biomass from each SBR completely oxidized ammonium or nitrite 
at similar rates as that of control (without ERY-H2O spiked) within 3 days (data not 
shown), indicating that ERY-H2O did not inhibit ammonium oxidation or nitrite 
oxidation in the short-term experiments, although ERY-H2O (50 µg/L in R1) caused 
microbial community shift in the long-term operation.   
Different from ERY-H2O, ERY (at concentrations of 100, 400, and 800 µg/L) 
inhibited the whole nitrification process, and the inhibition extent depended on the 
biomass–source and the ERY concentration.  For ammonium oxidation, significant 
difference of ERY inhibition was observed between biomass from R1 (ERY-H2O) 
and R2 (ERY) (p<0.01), R1 (ERY-H2O) and R3 (control; p<0.05) based on the 
statistical analysis of the 3-day product concentrations in the batch experiments.  For 
nitrite oxidation, difference of ERY inhibition was obvious on biomass from R1 
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(ERY-H2O) and R3 (control; p<0.01), but less obvious on biomass from R2 (ERY) 
and R3 (control) (p=0.07).  In addition, the difference of ERY inhibition on 
nitrification processes was studied in detail on the 2rd incubation day by using 
inhibition percentage (for the same biomass, 
 produced with ERY100% 1






× − − 
).  The maximum inhibition of 
ammonium oxidation by ERY (100, 400, and 800 µg/L) occurred on the biomass from 
R3 (control; 82–93%), followed by R2 (ERY; 71–95%) and R1 (ERY-H2O; 56–91%) 
after 48 h reaction (Fig. 3.7), indicating that the resistance of AOMs to ERY was in an 
order of R1 (ERY-H2O)>R2 (ERY)>R3 (control).  Similarly, the maximum inhibition 
of nitrite oxidation by ERY (100, 400, and 800 µg/L) also occurred on the biomass 
from R3 (control; 33–61%) after 48 h reaction, but ERY inhibited the nitrite oxidation 
similarly on the biomass from R1 (ERY-H2O; 21–42%) and R2 (ERY; 18–23%; Fig. 
5), indicating that the resistance of NOBs to ERY was in an order of R2 (ERY)≥R1 
(ERY-H2O)>R3 (control).  The results also demonstrate that ERY inhibited nitrite 
oxidation (18–61%) less significantly than ammonium oxidation (56–95%), which is 
consistent with the less NOBs diversity loss than AOMs as indicated by the 
PhyloChip readings (Table 3.1). 
 












































Fig. 3.7  In the batch experiments, a ammonium oxidation affected by ERY—(NO2-–
N + NO3-–N) produced in the batches of R1 (ERY-H2O; ▲), R2 (ERY; ◆) and R3 
(control; ■) after 48 h incubation; and b nitrite oxidation affected by ERY—NO3-–N 
produced in the batches of R1 (ERY-H2O; ▲), R2 (ERY; ◆) and R3 (control; ■) after 
48 h incubation.  The values represent means±standard deviations (n=3) 
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3.5     Discussion 
In this study, a relatively low concentration of ERY (100 µg/L) or dehydrated 
ERY (ERY-H2O; 50 µg/L) was investigated on their influences to the performance of 
the SBRs.  Both ERY and ERY-H2O showed negligible influence on carbon and 
nutrients (N and P) removal in the SBRs, which is consistent with the findings of the 
previous studies on even much higher concentrations of ERY (in mg/L range) (Amin 
et al., 2006; Oleinick, 1975).  In contrast, analyzed on high-density microarrays 
(PhyloChip), bacteria related to N and P removal changed in both diversity and 
abundance (reflected by fluorescence intensity) due to exposure to ERY-H2O (50 
µg/L) or ERY (100 µg/L).  The above observations could be explained by the 
selection of resistant bacteria, which are highly possible to be present in the 
inoculated activated sludge consisting of high diversity and density of bacteria 
(Kummerer, 2009a).  This could lead to a shorter adaptation time of bacteria against 
antibiotics via resistance, such as the ability to biodegrade antibiotics or the efflux of 
antibiotics to eliminate toxic effects.   
The resistant nitrifying bacteria selected upon exposure to low concentrations 
of the antibiotic ERY or its metabolite ERY-H2O was further confirmed in the short-
term batch experiments with higher concentrations of ERY at 100, 400, or 800 µg/L.  
This is one step further to answer the current open question about the resistance 
selection due to low concentrations of antibiotics in water by experimental data rather 
than by speculation (Hirsch et al., 1999).  Previous studies reported that ERY-H2O 
can induce Gram-positive Staphylococcus aureus RN 1389 to resist ERY (Majer, 
1981).  The present study demonstrates that ERY-H2O can also induce nitrifying 
bacteria, which are all known as Gram-negative bacteria, to resist ERY.  The biomass-
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source dependent inhibition of ammonium oxidation by ERY (R1 (ERY-H2O)<R2 
(ERY)<R3 (control)) suggests that AOMs acclimated to ERY-H2O (50 µg/L in R1) 
can create stronger resistance to ERY than AOMs acclimated to ERY (100 µg/L in 
R2).  Also, the biomass-source dependent inhibition of nitrite oxidation by ERY (R2 
(ERY)≤R1 (ERY-H2O)<R3 (control)) suggests that NOBs acclimated to ERY-H2O 
(50 µg/L in R1) can also create resistance to ERY.  This shed light on the problem 
that formation of antibiotic metabolites does not mean elimination of environmental 
impact of antibiotics.  In fact, some metabolites of antibiotics are more toxic to human 
than their parent drugs, such as acetyl derivative of sulfamethoxazole (Kummerer, 
2009a).  Additionally, current batch studies showed higher inhibition of ammonia 
removal (56–95%) and nitrate production (18–61%) by ERY (100, 400, and 800 
µg/L; Fig. 3.7) than previous inhibition study on ammonium oxidation (0.20%) and 
nitrate production (0.28%) at ERY of 1,000 µg/L (Nimenya et al., 1999).  The 
inhibition differences could be explained by different experimental conditions, such 
as Nimenya (1999) used shorter reaction duration, higher concentrations of nitrifying 
bacteria growing on the biofilms, and ERY solution prepared in deionised water at pH 
5.8.   
Different from nitrifying bacteria, the PhyloChip-observed information on 
PAOs and GAOs seems insufficient to explain the phenomena of the slightly 
improved phosphorus removal in R1 (than R2 and R3), which is mainly due to that 
PAOs and GAOs cover more complex but still largely uncertain genotypes than 
Rhodocyclus-related PAOs and GAO cluster (Seviour et al., 2003).  Therefore, more 
information is needed in the future study. 
In addition to the influence of ERY and ERY-H2O on SBRs, the fate of these 
antibiotics in the reactors is another concern.  As researchers suggested, the removal 
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of ERY or ERY-H2O in WWTPs is highly possible due to the sorption by high 
concentrations of suspended sludge (Giger et al., 2003; McArdell et al., 2003).  
However, the removal efficiency of ERY-H2O (70%) in R1 of this study was higher 
than those observed in the WWTPs at about 9–19% (Gulkowska et al., 2008) or ~ 
50% (Yang et al., 2006).  Besides possible biodegradation, the difference in sorption 
may be due to the different characteristics of the activated sludge.  The SBRs in this 
study were fed with synthetic wastewater containing only soluble and easily 
degradable glucose as organic carbon source, while the real WWTPs contain complex 
organic carbon source.  The different carbon sources could lead to the activated 
sludge with different extracellular polymeric substances, which would affect the 
sorption ability (Li and Yang, 2007).  In addition, the degradation of ERY is another 
concern during studying its effects on the nutrients removal.  Since neither ERY nor 
ERY-H2O was detected in the effluent of R2 (ERY) and biosorption has never been 
reported to have such high removal efficiency on ERY or ERY-H2O at even lower 
concentrations, ERY was suspected to be transformed to products other than ERY-
H2O.  Our discovery is different from previous studies in which the unchanged ERY 
was degraded easily to ERY-H2O in the aquatic environment (Giger et al., 2003; 
Hirsch et al., 1999; Karthikeyan and Meyer, 2006; Kolpin et al., 2002; McArdell et 
al., 2003; Richardson et al., 2005; Xu et al., 2007b).  The difference may be due to 
various pH values in the studies or may be due to biodegradation of ERY.  Further 
investigation is needed to identify the degradation mechanism of ERY and the 
degradation product(s). 
3.6     Conclusions  
In conclusion, ERY-H2O (50 µg/L) and ERY (100 µg/L) exhibit no 
unfavorable results on the efficiency of SBRs in treating the synthetic wastewater.  
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However, both compounds cause changes of microbial community composition in the 
reactors, which leads to the selected microorganisms more adaptive and resistant to 
the inhibitory effects of ERY and ERY-H2O.  This study suggests that the influence of 
ERY and ERY-H2O at the µg/L levels on treatment systems such as the complex 
wastewater treatment plants, one of the most highly antibiotics-exposed 
environments, is more likely to induce a pool of ERY resistance genes than to inhibit 






Chapter 4     
Proliferation of Antibiotic Resistance Genes in Microbial 
Consortia of SBRs upon Exposure to Trace ERY or ERY-
H2O 
 81 
4.1     Abstract 
A variety of antibiotics and their metabolites at sub-inhibitory level 
concentrations are suspected to expand resistance genes in the environment.  
However, knowledge is limited on the causal correlation of trace antibiotics or their 
metabolites with resistance proliferation.  In this study, ERY resistance genes were 
screened on microbial consortia of SBRs after one year acclimation to ERY (100 µg/L) 
or ERY-H2O (50 µg/L).  The identified esterase gene ereA explains that ERY could 
be degraded into six products by microbes acclimated to ERY (100 µg/L).  However, 
ERY could not be degraded by microbes acclimated to ERY-H2O (50 µg/L), which 
may be due to the less proliferated ereA gene.  Biodegradation of ERY required the 
presence of exogenous carbon source (e.g., glucose) and nutrients (e.g., nitrogen, 
phosphorus) for assimilation, but overdosed ammonium–N (>40 mg/L) inhibited 
degradation of ERY.  Zoogloea, a type of biofilm-forming bacteria, became 
predominant in the ERY degradation consortia, suggesting that the input of ERY 
could induce biofilm resistance to antibiotics.  Our study highlights that lower µg/L 
level of ERY or ERY-H2O in the environment encourages expansion of resistance 
genes in microbes.  
 
4.2     Introduction 
Antibiotics are detected in the environment such as hospital effluent, 
municipal wastewater, surface water, and groundwater (Kummerer, 2009a).  The most 
frequently detected antibiotics and their derivatives include trimethoprim, 
tetracycline, norfloxacin, penicillin G, cefalexin, cefotaxim, and dehydrated 
erythromycin (ERY-H2O), which are usually persistent in WWTPs (Kummerer, 
2009a).  The persistence of antibiotics may accelerate the development of resistance 
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genes and resistance bacteria by exerting selective pressure on microbes in the 
environment.  The occurrence and transfer of new combination of resistance genes are 
predicted to be much more frequent in the compartments with higher diversity and 
abundance of microorganisms (Murray, 1997), such as WWTPs that receive various 
antibiotics and their metabolites discharged from residential or hospital areas (Gros et 
al., 2007).  So far, it is not clear and far from complete whether antibiotics at 
concentrations as low as detected in hospital effluents (in the higher µg/L range) or in 
the aquatic environment (in the lower µg/L range) are important for the expansion of 
resistance in microbes (Kummerer, 2009b).  The correlation of input of antibiotics at 
lower environmental concentrations with the development or occurrence of antibiotic 
resistance genes is short of support with experimental data (Kummerer, 2009b).  
Other findings indicate that continuous input of resistant bacteria and resistance genes 
rather than the presence of antibiotics at sub-inhibitory concentrations may be more 
important for keeping resistance in the environment (Ohlsen et al., 2003; Ohlsen et 
al., 1998).  All these uncertainties have inspired researchers to investigate the fate of 
antibiotics and the occurrence of resistance in WWTPs and downstream natural water 
regions in the past decade (Le-Minh et al., 2010).  However, these investigations have 
been becoming increasingly difficult due to the lack of reference WWTPs free from 
input of resistance bacteria and genes.  Without a proper reference from an 
environmental system against resistance input, influence of antibiotics on resistance 
proliferation is inconclusive.     
Among the antibiotics studied, ERY has received less attention compared with 
other antibiotics in WWTPs since ERY is sensitive to pH.  At the operational pH 
ranges (6.5–8) of most municipal WWTPs, active ERY co-exists with its 
dehydrated-form ERY-H2O (Le-Minh et al., 2010).  Erythromycin-H2O is removed 
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mainly by sorption to sewage sludge in WWTPs via hydrophobic interactions and 
cation exchanges due to its surfactant-like structure, but its lower removal efficiency 
(9–19%) results in its higher concentration up to 6 µg/L in the effluent of WWTPs 
(Kummerer, 2009a; Le-Minh et al., 2010).  Moreover, ERY-H2O was reported to 
induce bacterial resistance as ERY does (Fan et al., 2009; Majer, 1981).  Accordingly, 
the occurrence of ERY derivatives other than ERY-H2O could also be possible to 
introduce microbial resistance.  Up to now, knowledge is still scarce on the 
contribution of ERY or other ERY derivatives (e.g., ERY- H2O) at µg/L levels in 
wastewater treatment systems to the amplification of resistance genes.     
Microbial resistant mechanisms to ERY include excretion of ERY by efflux 
pumps (e.g., efflux genes mefA/E and msrA/B), alteration of the target site to avoid 
binding of ERY (e.g., erythromycin ribosomal methylase genes erm), and destruction 
of ERY directly (e.g., esterase genes ereA and ereB, macrolide-2’-phosphotransferase 
gene mphA) (Amin et al., 2006; Wright, 2005).  Among these resistance genes, erm 
genes (A, B, C, E, F, T, V, and X), mef genes (A, E, and I), msrA, ereA/B, and mphA 
genes have been detected in wastewater and activated sludge of WWTPs, and ermB is 
the most prevalent gene in the environmental samples (Szczepanowski et al., 2009; 
Zhang et al., 2009).  Actually, all modes of ERY-related resistance genes can be 
found in both Gram-positive and Gram-negative bacteria 
(http://www.ncbi.nlm.nih.gov/), but intrinsic possession of efflux resistance on Gram-
negative bacteria’s membrane results in less sensitivity of them to ERY than Gram-
positive bacteria (Pechere, 2001).  Another mode of ERY resistance, destruction or 
the so-called biodegradation of antibiotics can be used as an indicator to interpret the 
function of antibiotic resistance genes.  Until recently, a few studies have tackled the 
possible biodegradation of ERY at different concentrations (Alexy et al., 2004; 
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Gartiser et al., 2007b).  A closed bottle test exhibited that ERY at concentrations of 
2.46 mg/L (equal to the theoretical oxygen demand (ThOD) of 5 mg/L) was not 
readily biodegradable by activated sludge (Alexy et al., 2004).  Erythromycin at 167 
mg /L (equal to TOC of 100 mg/L) could not be degraded completely and had evident 
inhibition on carbon removal (Gartiser et al., 2007b).  Noteworthy, the inocula 
utilized by the above studies were taken from WWTPs not receiving effluents from 
hospitals and were assumed to be less-adapted to antibiotics.  Biodegradation of 
antibiotics would rarely occur by non-selected microbes, that is, in the absence of 
resistance genes (Ding and He, 2010; Kummerer, 2009b).  In order to highlight effects 
of low concentrations of ERY and ERY- H2O on amplification of resistance genes, it 
is of significance to investigate biodegradation of ERY by microorganisms acclimated 
to ERY or ERY-H2O (in the µg/L range).   
The aim of this study is to identify the development of resistance genes and to 
investigate biodegradation of ERY with microbial consortia that have been acclimated 
to ERY (100 µg/L) or ERY-H2O (50 µg/L) for over one-year running with synthetic 
wastewater free from resistant bacteria and resistance genes input.  Findings of this 
study will provide significant information for the inadequate data on effects of trace 
antibiotics to promote resistance genes development in the aquatic and terrestrial 
environment.     
 
4.3     Materials and methods  
4.3.1    Batch experiments 
Biodegradability of ERY (10 mg/L, simulation of peak concentration in the 
effluent of pharmaceutical production plants) was tested in 250 ml flask bottles with 
inocula from steady state R1 (ERY-H2O of 50 µg/L), R2 (ERY of 100 µg/L), and R3 
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(control) after running over one year (the startup, operation methods and performance 
data of the three SBRs were described in chapter 3).  The inocula were freshly applied 
to short-term batch experiment.  Before being inoculated to flask bottles, the activated 
sludge of 1 ml withdrawn from the three steady state SBRs were washed three times 
with the same medium used in the batches.  Negative controls were prepared with 
autoclaved sludge to indicate possible ERY removal by non-biotic processes.  Bottles 
were filled with 50 ml of medium similar to the synthetic wastewater described above 
except for various concentrations of COD (contributed by glucose), NH4+–N, and 
PO43-–P in different batches as described below (Table 4.1).  (1) Effects of inocula 
source on degradation of ERY:  ERY degradation capability was tested with inocula 
from R1 (ERY-H2O), R2 (ERY), and R3 (control) by using medium containing COD, 
NH4+–N, PO43-–P, and ERY of 600, 30, 6, and 10 mg/L (COD:N:P = 100:5:1, as 
assimilation required), respectively.  (2) Effects of glucose on degradation of ERY:  
ERY (10 mg/L) degradation by inoculum from R2 (ERY) was tested in medium with 
glucose equal to 600 mg/L COD or without glucose.  Other elements in the medium 
were exactly the same as above mentioned (e.g., NH4+–N of 30 mg/L and PO43-–P of 
6 mg/L).  (3) Effects of ammonium and phosphate on degradation of ERY: 
Degradation of ERY (10 mg/L) was tested with inocula from R2 (ERY) by using 
medium containing 600 mg/L COD, 6 mg/L PO43-–P and gradient concentrations of 
NH4+–N (30, 40, 50, and 60 mg/L), or 30 mg/L NH4+–N and gradient concentrations 
of PO43-–P (6, 13, 20, and 26 mg/L).  All the above experiments were performed in 
triplicates.  The flask bottles were placed on a shaker for mixing and aeration at room 
temperature (25–27°C).  The pH ranged from 6.9 to 8.1 during one batch of 
experiments without adjustment.  Samples from batch conical flasks were collected 
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daily and centrifuged at 14,000 rpm for 15 min at 25°C.  Therefore, the measured 
phosphate and all kinds of nitrogen were in dissolved forms throughout this study.     
 
Table 4.1 Batch experiments to study effects of inocula source, glucose (calculated as 
COD), NH4+–N, and PO43-–P on biodegradation of ERY (10 mg/L)  








Inocula source R1, R2, and R3 600 30 6 
Glucose R2 600 and 0 30 6 
Ammonium R2 600 30, 40, 50, and 60 6 
Phosphate R2 600 30 6, 13, 20, and 26  
 
4.3.2    Analytical methods  
As described in chapter 3, an ion chromatography was used to measure 
dissolved PO43-–P, NO3-–N, NO2-–N and NH4+–N, and a LC-MS-MS was applied to 
detect both ERY and ERY-H2O.   Products of ERY were full-scanned by LC-MS over 
the m/z range of 100–1000 amu. 
 
4.3.3    DNA extraction and polymerase chain reaction (PCR)  
The genomic DNA of 1 ml of mixed liquid from the SBRs was extracted and 
purified by using DNeasy Tissue Kit (QIAGEN GmbH, Germany) with modified 
method as described in chapter 3 (Fan et al., 2009).  The obtained DNA was 
quantified on a Nanodrop-1000 (NanoDrop Technologies Inc., USA). 
PCR (Eppendorf, Germany) amplification of 16S rRNA genes was performed 
by using universal eubacterial primers 8F (Zhou et al., 1995) and 1392R (Lane et al., 
1985).  The fluorescently labeled forward primer 8F-cy5 was used to amplify 16S 
rRNA genes for T-RFLP.  Erythromycin resistance genes, including esterase genes 
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ereA and ereB, phosphotransferase gene mphA, efflux genes mefA/E and msrA/B, 
and methylase genes ermA, ermB, and ermC, were PCR (Eppendorf, Germany) 
amplified by using primers described previously (Sutcliffe et al., 1996). PCR products 
were subsequently visualized on a Molecular Imager Gel Doc XR System (Bio-Rad, 
USA).  
 
4.3.4    T-RFLP 
The fluorescently labeled 16S rRNA genes were digested with 5 U of 
restriction endonucleases HhaI, MspI, or RsaI (NEB, USA) as described previously 
(He et al., 2003).  The terminal restriction fragments (T-RFs) were determined on a 
CEQ 8000 automated sequencer (Beckman Coulter, USA) by using GenomeLab™ 
Fragment Analysis Kit Insert (608113-AH) and internal standard (DNA Size Standard 
Kit – 600, p/n 608095) (Beckman Coulter, USA).  Individual T-RFs were normalized 
as a percentage of the total peak area.  
 
4.3.5    Clone library and sequencing  
A 16S rRNA gene clone library was established by using TOPO-TA cloning 
kit (Invitrogen, USA) according to the manufacturer’s recommendation.  The 16S 
rRNA gene inserts were PCR-amplified with TA primers (Zhou et al., 1997) and then 
digested with enzyme HhaI or MspI (NEB, USA).  Plasmid DNA was purified with 
Qiagen Miniprep kit (Qiagen GmbH, Germany) and subsequently sequenced on an 
ABI 3100 Sequencer (Applied Biosystems, USA) by using primers M13F-20, M13R-
24, 533F, 529R, 907F (http://www.genomics.msu.edu).  Sequences were aligned and 
analyzed by using BioEdit assembly software 
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(http://www.mbio.ncsu.edu/BioEdit/bioedit.html) and BLAST 
(http://www.ncbi.nlm.nih.gov/), respectively.  
 
4.4     Results 
4.4.1    Effects of ERY and ERY-H2O on expansion of resistance genes 
Erythromycin resistance genes were screened on microbial consortia in the 
SBRs (Table 4.2 and Fig. 4.1).  Esterase genes ereA and ereB, efflux gene mefA/E, 
and methylase gene ermA were detected in the microbes of MR (before 8-month 
pretreatment).  After 8-month pretreatment, ereA, ereB, and ermA genes disappeared 
in the MR and the latter two genes did not recover in any reactors regardless of the 
one year addition of ERY or ERY-H2O; mefA/E always appeared at a lower level in 
the MR and kept in all three SBRs (R1, R2, and R3) in the following one more year 
operation.  Interestingly, though ereA gene was not detected in the MR after 8-month 
pretreatment, it bounced back in R1 (ERY-H2O) and R2 (ERY), but was not detected 
in R3 (control).  No any other factors were different in the three SBRs except the 
presence/absence of ERY-H2O or ERY.  Thus, both ERY-H2O (50 µg/L in R1) and 
ERY (100 µg/L in R2) exhibited significant effects on proliferation of the resistance 
gene ereA.    
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Table 4.2 Resistance genes detected in MR, R1 (50 µg/L of ERY-H2O), R2 (100 
µg/L of ERY) and R3 (control) 
 
                     Month 
Function    
-8 0 12 12 12 
Gene MR MR R1(ERY-H2O) R2(ERY) R3(control) 
ereA Erythromycin 
esterase 
+ a －b + ++ c － 
ereB + － － － － 
mphA Macrolide-2’-
phosphotransferase 
－ － － － － 
mefA/E Macrolide efflux ++ + + + + 




－ － － － － 
ermB + － － － － 
ermC － － － － － 




Fig. 4.1 Detection of esterase genes ereA and ereB in the microbes of mother reactor 
(MR), R1 (ERY-H2O), R2 (ERY), and R3 (control).  Lane 1, GenerulerTM 100 bp Plus 
ladder (Fermentas); lanes 2-7, 420 bp PCR products of ereA in the microbes of MR 
(month -8 and 0), R1, R2 and R3 (month 12), and negative control (NC); lanes 8-13, 
546 bp PCR products of ereB in the microbes of MR (month -8 and 0), R1, R2 and R3 
(month 12), and NC. 
 90 
 
4.4.2    Biodegradation of ERY 
Microbial consortia containing esterase gene ereA may be capable of 
esterifying ERY.  Therefore, microorganisms from R1 (ERY-H2O), R2 (ERY), and 
R3 (control) were tested on their capability to degrade ERY (10mg/L) in batch bottles 
with a medium containing COD, NH4+–N, and PO43-–P of 600, 30, and 6 mg/L 
(COD:N:P = 100:5:1, as assimilation required), respectively.  A remaining percentage 
of ERY (concentration of ERY in the tested bottles compared to that in negative 
controls with autoclaved inocula) was used to indicate biodegradation of ERY.  
During five days incubation, remaining percentage of ERY was constantly ~ 100% in 
the batches with inocula from R1 (ERY-H2O) or R3 (control), indicating that ERY-
H2O (50 µg/L in R1 running over one year) could not acclimate microbes to degrade 
ERY (Fig. 4.2).  In contrast, ERY in batches with inocula from R2 (ERY) was 
completely removed within 3 days, indicating that ERY (100 µg/L in R2 running over 
one years) induced microbes to degrade ERY (Fig. 4.2).  In addition, similar batches 
were setup to test biodegradation of ERY-H2O, but results showed that ERY-H2O was 






















Fig. 4.2 Degradation of ERY in the batches with inocula from R1 (ERY-H2O), R2 
(ERY), and R3 (control).  A percentage of ERY is determined by the concentration of 
ERY in the tested bottles compared to that in the negative control bottles with 
autoclaved inocula.  The values represent an average (n=3), and the standard 
deviations (less than 6%) were not shown. 
 
To investigate the degradation products of ERY, LC-MS-MS was used to 
monitor the precursor ion of ERY with a mass-to-charge ratio m/z 734.5/158.2 amu.  
The LC-MS-MS chromatograms demonstrated that two main peaks were eluted at a 
retention time of 5 min and 10 min with the disappearance of ERY in the batches with 
inocula from R2 (ERY at 100 µg/L), suggesting that at least two products (product I 
and II) with the same precursor ion m/z ratio as ERY were produced (Fig. 4.3a).  
Furthermore, biodegradation products of ERY were fully scanned using LC-MS (m/z 
100-1000 amu), the chromatogram of which exhibited six products (Fig. 4.3b).  
According to the mass spectra of these six products, four products with the same 
precursor ion m/z ratio (735 amu) as ERY appeared at a retention time of 4.6 (product 
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II), 9.2, 9.6, and 10.3 min (product I); and the other two products with lower m/z 
ratios (718 amu and 720 amu) of precursor ions than ERY eluted at 9.9 min and 10.6 
min, respectively (Fig. 4.4).  The six products, possessing either the same or 15–17 
amu lower m/z ratios of precursor ions (735, 720, and 718 amu) than ERY (m/z 735 
amu), are good matches of the downstream products of esterified ERY as reported 
previously by isolates of Escherichia coli, Providencia stuartii, Staphylococcus 
aureus, and Pseudomonas sp. (Wright, 2005).   
  
Fig. 4.3 Biodegradation products of ERY.  a — The LC-MS-MS chromatograms 
(734.5/158.2 amu) exhibit the degradation products of ERY in the batches of R2 
(ERY) (shown in Fig. 4.2) after incubation for 0 day, 2 days and 3 days. 
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Continued Fig. 4.3 Biodegradation products of ERY.  b — The LC-MS 
chromatograms (full-scan with m/z 100–1000 amu) exhibit the degradation products 





Fig. 4.4 Mass spectra of peaks in the Fig. 3b: peaks at retention time (a) 4.6 min 







Continued Fig. 4.4 Mass spectra of peaks in the Fig. 3b: peaks at retention time (e) 








Based on the degradation products and previous reported esterase mechanism 
of ERY (Wright, 2005), the possible pathway for ERY biodegradation was shown in 
Fig. 4.5.  The formation of two main products I and II (m/z 735 amu) from ERY may 
follow four steps: 1) esterase enzyme cleaves the macrocycle ester via adding one 
H2O molecule, 2) non-enzymatic intramolecular hemiketal formation (one ERY –OH 
group transformed), 3) internal dehydration to form enol ether product I, or a second 
internal cyclization event via intramolecular condensation and dehydration to form 
product II (one ERY –OH group transformed), 4) Product I transferred to product II 
(one ERY –OH group transformed).  The other two products with precursor ion m/z 
ratios (735 amu) may share the same formation mechanism with the products I and II 
at the first 2 steps, but differ in dehydration positions at the third step. The two 
products with precursor ion m/z ratios (720 and 718 amu) may be dehydrated twice at 
the third step (at most two ERY –OH groups transformed) and followed by saturation 
with several –H.  Overall, biodegradation of ERY seemed to transform 1–3 –OH 
groups.  As most of –OH groups of ERY are active groups for antibiotic activity 
(Schlunzen et al., 2001), the biodegradation products of ERY may lose or weaken 






























































































































Erythromycin (735 amu) Erythromycin carboxylic acid (753 amu)
Erythromycin-6,9 hemiketal 
carboxylic acid (753 amu)
Anhydroerythromycin-6,9 hemiketal 
carboxylic acid (product II, 735 amu)
Erythromycin enol ether 
carboxylic acid (product I, 735 
amu)
 
Fig. 4.5 Reaction and downstream products of ERY esterases. 
 
4.4.3    Effects of glucose, ammonium and phosphate on biodegradation of ERY 
Since most of ERY esterase-producing microbes, such as E. coli and S. aureus 
(Wondrack et al., 1996), are known as heterotrophic bacteria, it is necessary to assess 
the influence of exogenous carbon source (e.g., glucose) on ERY biodegradation.  The 
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medium containing NH4+–N (30 mg/L) and PO43-–P (6 mg/L) was prepared in two 
conditions with or without glucose (equal to COD of 600mg/L) and received inocula 
from R2 (ERY).  In the medium without glucose, 10 mg/L ERY did not show any 
obvious decrease compared with negative control.  In the medium containing glucose, 
however, ERY decreased quickly from 10 mg/L to ~1 mg/L within 3 days (Fig. 4.6a), 
suggesting that the exogenous carbon source (e.g., glucose) was necessary for 
degrading ERY.     
To evaluate effects of ammonium and phosphate on ERY biodegradation, the 
medium containing different initial concentrations of NH4+–N (30, 40, 50, and 60 
mg/L) and PO43-–P (6, 13, 20, and 26 mg/L) was tested on inocula from R2 (ERY).  
In batches with different phosphate concentrations (NH4+–N of 30 mg/L and COD of 
600 mg/L), ERY degradation was similar for all batches (Fig. 4.6b), excluding the 
effects of phosphate on the biodegradation of ERY.  Ammonium, however, was 
shown to greatly inhibit the biodegradation of ERY (Fig. 4.6c).  When inocula were 
fed with NH4+–N of 30 mg/L (theoretically just sufficient for assimilation of 600 
mg/L COD), ERY of ~9 mg/L (90%) was biodegraded; whereas with higher 
concentrations of NH4+–N, ERY of 7 mg/L (70%, NH4+–N of 40 mg/L), and 3 mg/L 












































Fig. 4.6 The effects of a — glucose, and b — phosphate on the biodegradation of 


























Continued Fig. 4.6 The effects of c — ammonium on the biodegradation of ERY.  
The values represent the means ± standard deviations (n=3).  NC means negative 
control. 
4.4.4    Shift of microbial communities due to ERY biodegradation  
T-RFLP and clone library were employed to find out the shift of microbial 
communities due to ERY biodegradation. 
Change of community structure due to ERY biodegradation 
The DNAs extracted from batch samples that ERY (10 mg/L) was completely 
biodegraded by inocula from R2 (ERY) were applied to T-RFLP analysis.  The T-
RFLP results showed that microbial community changed during ERY biodegradation 
process (Fig. 4.7).  At the end of ERY degradation, T-RFLP distinguished three 
dominant T-RFs with the sizes of 206 base pairs (bp), 492 bp and 121 bp digested by 
the enzymes HhaI, MspI, and RsaI, respectively.   
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Fig. 4.7 T-RFLP results for the samples in the degradation batches of R2 (ERY).  a, b 
and c — the sample on day 0 before ERY degradation; a’, b’ and c’ — the sample on 
the day that ERY was completely degraded.  Peaks less than 1% were not shown. 
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Continued Fig. 4.7 T-RFLP results for the samples in the degradation batches of R2 
(ERY).  a, b and c — the sample on day 0 before ERY degradation; a’, b’ and c’ — 
the sample on the day that ERY was completely degraded.  Peaks less than 1% were 
not shown. 
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Continued Fig. 4.7 T-RFLP results for the samples in the degradation batches of R2 
(ERY).  a, b and c — the sample on day 0 before ERY degradation; a’, b’ and c’ — 
the sample on the day that ERY was completely degraded.  Peaks less than 1% were 
not shown. 
 
Identification of the predominant species by clone library  
To identify the species represented by the predominant T-RFs, a 16S rRNA 
clone library was established with the same genomic DNA as that in the T-RFLP.  
Restriction analysis of amplified ribosomal DNA (by MspI and HhaI) generated two 
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dominant patterns (16 and 10 clones from 72 clones, respectively).  Sequence results 
of the two patterns revealed that they were reversely complementary.  Therefore, 36% 
of the clones represented one dominant species.  The sequence results also showed 
that the dominant species possess 98% similarity of the 16S rRNA gene sequence of 
Zoogloea (DQ413151.1), a well-known producer of extracellular polymeric 
substances (EPS) that is vital in maintaining activated sludge floc.  Consequently, 
bacteria in floc or biofilm increase antibiotic resistance 10 to 1,000 folds comparing to 
their planktonic formation (Anderson and O'Toole, 2008).  Also, the dominant species 
exhibit the same T-RFs as those dominant T-RFs in the T-RFLP results based on the 
analysis of sequence by BioEdit assembly software.    
 
4.5     Discussion  
The presence of antibiotics and the continuous input of resistant bacteria and 
genes are considered as two main factors for the amplification of resistance 
(Kummerer, 2009b).  Here in the absence of continuous resistant microorganisms and 
genes input via using synthetic wastewater, proliferation of esterase gene ereA as well 
as esterificaiton of ERY to 6 products was observed with microbes exposed to ERY 
(100 µg/L) for over one year, indicating that long-term exposure to ERY can induce 
resistance development in microbes.  Therefore, the causal relationship of antibiotics 
at concentrations as low as found in the environment with expansion of resistance 
genes is strongly supported in this study by experimental data rather than by 
hypothesis in previous studies (Kummerer, 2009b).  This discovery is inconsistent 
with other findings that ERY (up to 100 µg/L) is too low to sustain antibiotic 
resistance and continuous introduction of resistance genes may be more important for 
resistance expansion in the sewage (Ohlsen et al., 2003; Ohlsen et al., 1998).  The 
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difference may be due to an over-simplified microbial community (two kinds of 
bacteria, one donor and one recipient for resistance genes) being operated over short 
time (10 days) in those studies, which may underestimate the transfer frequency and 
sustain of resistance genes in the ecosystem.    
The ERY derivatives (e.g., ERY-H2O) can be very persistent (Kummerer, 
2009a), which makes complete mineralization of ERY difficult (Alexy et al., 2004; 
Gartiser et al., 2007b).  The intermediates during antibiotics degradation was usually 
reported to possess negligible antibacterial activity due to that bacteria can directly 
destruct antibiotic functional groups or modify the macrolide antibiotics to gain 
resistance (Schlunzen et al., 2001; Wright, 2005).  However, they may also induce 
microbial resistance to the parent drugs (Fan et al., 2009; Majer, 1981).  Current study 
on ERY-H2O further proved the above resistance development principle, although the 
developed resistance gene ereA in this study cannot induce enzyme immediately to 
degrade ERY.  Similar as ERY-H2O, other biodegradation products of ERY may also 
show no antibiotic activity due to the lost of several antibiotic functional –OH groups 
but may still induce microbial resistance to ERY (Schlunzen et al., 2001).  Further 
study is needed to find out whether the degradation products of other antibiotics can 
still induce resistance to their parent drugs as ERY-H2O does to ERY (Fan et al., 
2009; Majer, 1981).     
Antibiotics or their structure closely related derivatives at sub-inhibitory 
concentrations may act as signals to trigger specific response in micro-ecosystem to 
resistant antibiotics (Fajardo and Martinez, 2008).  Erythromycin at sub-inhibitory 
concentrations has been reported to activate expression of specific gene encoding for 
polysaccharide (one of important components of EPS) intercellular adhesion in 
Staphylococcus (Rachid et al., 2000).  Thus, ERY and Zoogloea may follow similar 
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interactions as shown in the above study.  Erythromycin may trigger the Gram-
negative Zoogloea to become dominant and to form protective biofilms, since the 
presence of intrinsic efflux resistance genes in Gram-negative bacteria can make them 
more impermeable and less sensitive to ERY (Pechere, 2001).  Bacteria containing 
ereA gene are speculated to be located at the outer edges of Zoogloea formed biofilm 
to eliminate antibiotics from harming the inner microbes.  In turn, both microbes 
containing ereA gene and biofilm cells work together to provide sufficient antibiotic 
resistance in the microbial communities.  Moreover, long-term treatment of bacteria 
with lower antibiotic concentrations has been discovered to result in higher resistant 
capability of biofilm populations of E. coli than planktonic bacteria (Harrison et al., 
2005).  Further study is needed to clarify gene-based biofilm resistance to antibiotics 
at low concentrations (e.g., in WWTPs).  Notably, full-scale WWTPs may show more 
frequent resistance gene development and transfer than in this study, which could be 
caused by (1) wastewater properties–complex wastewater versus synthetic 
wastewater; (2) diversity of microbial communities–complex versus enriched 
microbial consortia; (3) frequent resistant bacteria and genes input versus free of these 
two sources (Szczepanowski et al., 2009; Zhang et al., 2009).  Also, since ERY is 
sensitive to pH, it may be dehydrated into ERY-H2O in wastewater collection 
pipelines before entering WWTPs.  Consequently, ERY does not have a chance to be 
esterified in WWTPs, but ERY-H2O becomes prevalent there as reported previously 
(Le-Minh et al., 2010).     
Higher concentrations of ammonium (NH4+–N>40 mg/L) were found to 
inhibit ERY biodegradation for more than 30% (Fig. 4.6), which may be explained by 
the toxicity of free ammonia (when NH4+–N–N =60 mg/L, pH=8.1, T=27°C, NH3–N 
=4.6 mg/L) to most microorganisms.  Considering NH4+–N of 60 mg/L in the 
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synthetic wastewater was diluted to a final concentration of 30 mg/L in the influent of 
R2 (ERY of 100 µg/L, a dilution factor of 2) (Fan et al., 2009), this concentration of 
ammonia did not inhibit the ERY biodegradation.  However, in the sewage treatment 
plants (STPs) receiving antibiotics discharged from both hospitals and households, 
ammonium concentrations fluctuate during the day (could be > 40 mg/L) and dilution 
factors are process-dependent (usually < 2), which is more likely to inhibit the 
biodegradation of ERY.  Moreover, the even higher concentrations of ammonium in 
separate sewage system and in pharmaceutical wastewater will definitely make ERY 
biodegradation more difficult to occur.  The untreated ERY, in turn, will inhibit 
ammonium oxidization (Alexy et al., 2004; Nimenya et al., 1999).  Awareness is 
needed to optimize STPs to cope with this problem.  
 
4.6     Conclusions  
In conclusion, both ERY-H2O (50 µg/L) and ERY (100 µg/L) can encourage 
development of ERY esterase gene ereA under conditions of free input of resistant 
bacteria and genes.  Dehydrated erythromycin acclimated microbes cannot esterify 
ERY as ERY acclimated ones do, which may be due to the less proliferated ereA 
gene.  This study suggests that the presence of ERY and ERY-H2O at concentrations 
as low as found in the environment can enhance establishment of antibiotic resistance, 
and will provide important information to substantiate correlation between resistance 







Chapter 5     
Loss of Bacterial Diversity and Enrichment of 
Betaproteobacteria in Microbial Consortia of SBRs Exposed 
to Trace ERY and ERY-H2O  
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5.1     Abstract  
The increasing use of antibiotics may contribute to the selection of antibiotic 
resistant bacteria in micro-ecosystems.  This has led us to study long-term effects of 
antibiotics ERY (100 µg/L) and its derivative ERY-H2O (50 µg/L) on the SBR 
microbial communities.  Culture-independent analyses on 16S rRNA genes, including 
T-RFLP, denaturing gradient gel electrophoresis (DGGE) and microarrays 
(PhyloChip), were applied in this study.  Results revealed that both ERY and ERY-
H2O had similar inhibitory and selective spectrum to significantly alter the 
phylogenetic structures of the SBR microbial communities.  The Gram-positive 
Actinobacteria and Gram-negative Proteobacteria were inhibited in terms of both 
diversity and abundance.  The selected bacteria were enriched in abundance, which 
belonged to the TM7 phylum, as well as the β-Proteobacteria subphylum within the 
Rhodocyclaceae family (within the genera of Azonexus, Dechloromonas, Thauera, 
and zoogloea) and the Nitrosomonas genus.  The enriched zoogloea are capable of 
forming biofilm to resist antibiotics, and the nitrate-reduction Azonexus, 
Dechloromonas and Thauera, as well as the ammonium-oxidization Nitrosomonas are 
able to remove the toxic nitrogenous  substances accumulated in the biofilm.  With 
phylogenetic analysis on uncultured samples, our results suggested that low levels of 
ERY or ERY-H2O can affect micro-communities by the inhibition of sensitive 
bacteria and the enrichment of biofilm antibiotic resistant bacteria. 
 
5.2     Introduction 
The sub-inhibitory concentrations of antibiotics in the environment are 
suspected to account for the rapid development and spreading of resistant pathogens, 
which greatly imperil the therapeutic usage of antibiotics.  The antibiotics in the 
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environment are mainly released via anthropogenic activities, the massive production 
and the improper utilization of antibiotics (e.g., in the treatment of virus-caused 
diseases and in the promotion of animal growth) (Aminov, 2009; Davies and Davies, 
2010).  However, both efforts to discover the new antibiotics and to control the usage 
of antibiotics have failed to effectively cope with the proliferation of antibiotic 
resistant microorganisms.  This is due to the lack of knowledge on the natural roles of 
antibiotics in the environment.  Different from higher to lethal concentrations of 
antibiotics that act as a stress to inhibit or kill microorganisms, sub-inhibitory 
concentrations of antibiotics in the environment are recently recognized to play the 
signaling and regulatory roles in micro-ecosystems (Davies et al., 2006; Linares et al., 
2006; Martinez, 2008; Yim et al., 2006).  For example, low-dose antibiotics have been 
found to definitely induce antibiotic resistance genes as the genotypic response of the 
opportunistic pathogen Pseudomonas aerugenosa, and to increase/decrease alginate 
production and biofilm volume as their phenotypic response (Aminov, 2009).  Most of 
this updated knowledge on the natural roles of antibiotics was based on the 
investigations of pure isolates.  Few studies have been conducted on the microbial 
communities exposed to the low concentrations of antibiotics in the environment, 
where the regulation impact of antibiotics are expected to be more complex due to the 
higher density and diversity of microorganisms.   
As the main collection pools of antibiotics and antibiotic resistant bacteria, 
WWTPs are posing increasing threat to human beings because of the wide usage of 
the recycled wastewater (e.g., as portable and non-portable water sources) (Le-Minh 
et al., 2010).  The antibiotics erythromycin (ERY) and its derivative ERY-H2O are  
with the lowest removal rate in WWTPs (Rosal et al., 2010).  Therefore, ERY and 
ERY-H2O are most frequently detected in downstream water bodies (e.g., surface 
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water, ground water and untreated drinking water sources) (Focazio et al., 2008).  
Many types of ERY resistance genes (ribosomal methylase genes erm (A, B, C, E, F, 
T, V, and X), efflux genes mef (A, E, and I) and msrA, esterase genes ereA/B, and 
macrolide-2’-phosphotransferase gene mphA) have been detected in wastewater and 
activated sludge of WWTPs (Szczepanowski et al., 2009; Zhang et al., 2009).  And 
the proliferation of ereA gene has been reported as the result of low concentrations of 
ERY or ERY-H2O in the lab-scale SBRs (Fan and He, 2011).  As phenotypic response 
to sub-inhibitory concentrations of ERY,  isolate Staphylococcus have been reported 
to activate expression of specific gene encoding polysaccharide (one of important 
components of biofilm extracellular polymeric substances (EPS) matrix) for 
intercellular adhesion (Rachid et al., 2000).  Biofilm populations of Escherichia coli 
have been discovered to possess higher resistant capability than planktonic bacteria 
when treated with lower concentrations of antibiotics for longer time (Harrison et al., 
2005).  However, the phenotypic response of microbial communities to low-dose 
antibiotics (e.g. ERY) in WWTPs has rarely been conducted.  This is due to the lack 
of antibiotics-uncontaminated WWTPs as negative controls and the disturbance of 
antibiotic resistant bacteria brought by wastewater.  In addition, there is a limit of 
technologies that can comprehensively target the massive un-culturable 
microorganisms in the environment (e.g., WWTPs).  All these reasons may result in 
the difficulties to discover the less pronounced effects of antibiotics at lower 
concentrations (Ding and He, 2010).   
Since the majority of microorganisms in natural environments, such as 
WWTPs, are not culturable (Amann et al., 1995), uncultured-methods are developed 
to detect, characterize and quantify microbes in natural systems.  These uncultured-
methods are usually based on molecular approaches, classifying heterogeneous 
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nucleic acids via the universal 16S rRNA genes (DeSantis et al., 2007).  The tools 
used to categorize 16S rRNA genes include clone libraries to identify the bacterial 
species present, as well as the rapid and high-throughput methods of T-RFLP and 
denaturing gradient gel electrophoresis (DGGE) to qualitatively describe the spatial 
and temporal changes in microbial communities.  Different from above tools that only 
profile the dominant organisms of a complex bacterial population and have to 
accompany sequencing to characterize taxonomic nomenclature of each group, a 
higher-density and more throughput oligonucleotide microarray (PhyloChip) was 
designed to target more taxa by vastly increasing the total number of probes and has 
been successfully applied in different environmental samples (DeSantis et al., 2007; 
DeSantis et al., 2005; Hazen et al., 2010).     
The aim of this study is to identify phylogenetic structure change of SBR 
microbial consortia due to being acclimated to ERY (100 µg/L) or ERY-H2O (50 
µg/L) for over one-year running with synthetic wastewater free from resistant bacteria 
and resistance genes input.  The 16S rRNA genes based uncultured methods, 
including T-RFLP, DGGE and PhyloChip microarray, were used to statistically 
evaluate shift of microbial communities and further to identify enriched and inhibited 
microbial taxa.  The result will help to enlarge the knowledge about effects of low 
dose antibiotics to regulate microbes in WWTPs.     
 
5.3     Materials and methods 
5.3.1    DNA extraction, PCR, and T-RFLP 
The startup, operation methods and performance data of the three SBRs were 
described in chapter 3.  The genomic DNA of mixed liquid from the SBRs were 
extracted with the method described in chapter 3.  According to the methods 
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described in chapter 4, each DNA pool extracted from triplicate sludge samples was 
duplicated applied to PCR for the amplification of the 16S rRNA genes with 
eubacterial primers 8F-cy5 (Zhou et al., 1995) and 1392R (Lane et al., 1985), the 
amplified 16S rRNA genes were digested with 5 U of restriction endonucleases HhaI 
(NEB, USA) (He et al., 2003) for following T-RFs determination, and then the 
individual T-RFs were normalized as a percentage of the total peak area.  
 
5.3.2    PhyloChip  
The high-density phylogenetic 16S rRNA gene microarrays (PhyloChip) 
employed in this study contain 1,440 distinguishable prokaryotic operational 
taxonomic units (OTUs) identified by 35,000 probes, which were designed according 
to the approach described previously  (DeSantis et al., 2003).  Each DNA pool 
extracted from triplicate sludge samples was tested on triplicate PhyloChips.  The 
archaeal and bacterial 16S rRNA gene were amplified using PCR with primers 27F 
(5’-AGAGTTTGATCCTGGCTCAG-3’) and 1492R (5’-
GGTTACCTTGTTACGACTT-3’) for bacteria and 4Fa (5’- 
TCCGGTTGATCCTGCCRG-3’) and 1492R for archaea according to the previous 
method (Hazen et al., 2010).  PhyloChip processing (Brodie et al., 2006; Hazen et al., 
2010), scanning, OTU scoring, and normalization were all performed as previously 
described (Brodie et al., 2006; DeSantis et al., 2007; Flanagan et al., 2007; Hazen et 
al., 2010) with some minor modification.  A probe pair was considered positive when 
the difference in intensity between the perfect match (PM) and mismatch (MM) 
probes must be at least 130 times the squared noise value (N).  A taxon was 
considered to be present in the sample needs two criteria: (1) 90% or more of its 
assigned probe pairs for its corresponding probe set were positive (positive fraction, 
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≥0.90), and (2) positive fractions of this taxon tested in triplicate PhyloChip were all 
≥0.90.  After probe intensities were array-normalized by scaling to the internal 
standards, a significantly linear correlation was established between the 
log2(concentrations) of each internal standard gene and the corresponding intensity 
(average correlation coefficient r = 0.0029, and average intercept = -1.4501).  
Therefore, a change in intensity of 400 units is approximate to a 2.23-fold change in 
gene copy number.   
 
5.3.3    PCR–DGGE 
PCR-DGGE analyses were carried out for universal bacterial 16S rRNA gene 
amplified with primer pair 8F-GC (5’- 
CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGGAGAGTTTGA
TCCTGGCTCAG-3’) (Muyzer et al., 1993; Reysenbach et al., 1994) and 518R (5’-
ATTACCGCGGCTGGCTGG-3’) (Muyzer et al., 1993).  PCR amplified fragments 
were electrophoresed on an 8% polyacrylamide gel with a 30–70% urea–formamide 
gradient for 16 h at 120V and 60°C. 
Selected DGGE band fragments were excised with sterile razors, washed with 
sterile deionized water, and then placed in 50 µL of DNA elution buffer (QIAGEN 
GmbH, Germany) overnight.  The eluted DNA was used in PCR reaction with 
primers without GC-clamps, 8F and 518R.  The PCR products were purified with 
PCR purification kit (QIAGEN GmbH, Germany) and subsequently sequenced on an 
ABI 3100 Sequencer (Applied Biosystems).  Sequences were analyzed with BioEdit 
assembly software (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) and BLAST 
with similar sequences in GenBank (http://www.ncbi.nlm.nih.gov/).  Phylogenetic 
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tree of 16S rRNA gene sequenced from DGGE bands were constructed with the 
neighbor-jointing method ordination of ρ-distance by software MEGA 4. 
 
5.3.4    Statistical analysis 
Nonmetric Multidimensional Scaling  
Nonmetric multidimensional scaling (NMDS) plots facilitate the exploration 
of similarities and dissimilarities through visualization of data sets.  To obtain a 
NMDS plot, a similarity matrix derived from the data sets of 16S rRNA gene 
sequences, including (A) the PhyloChip intensities after normalized with whole chip 
intensities and (B) the percentages of T-RFs, were first generated based on Bray-
Curtis distance with or without square-root transformation, respectively.  The matrix 
then undergoes a 100-iterations NMDS analysis.  Nonmetric multidimensional scaling 
plot analyses were subsequently performed with the software Primer 5 
(http://www.primer-e.com/). 
 
Indentifying dynamic subfamilies 
An OTU consists of a group of one or more 16S RNA sequences with 
typically 97 to 100% sequence homology, while a subfamily consists of a group of 
OTUs with typically no less than 94% sequence homology.   
When summarizing PhyloChip results to subfamily, the taxon with a probe set 
producing the highest mean intensity within the subfamily was used.  To identify the 
most dynamic 16S rRNA gene amplicons, hierarchical clustering was performed on a 
prefiltered subfamilies list containing only the 100 most variable subfamilies (based 
on standard deviation).  This was performed with the software Cluster 3.0.  Both 
samples and subfamilies were clustered with Pearson correlation as the distance 
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metric and unweighted pair group method with arithmetic mean (UPGMA) as the 
linkage method. The cluster result was visualized with the software TreeView.  
 
Indentifying variable OTUs and subfamilies  
In case of losing information of OTUs with non-highest intensity within a 
subfamily, statistical analysis was firstly performed on all taxa and then the results 
were summarized to subfamily.  Significantly inhibited OTUs in R1 (ERY-H2O of 
50ug/L) or R2 (ERY of 100μg/L) were defined as those present in R3 sample, 
achieving a probability values p<0.05 with Student’s t-test upon log2(concentration), 
and an decrease in mean intensity compared to R3 (control) of >400 units and >30%.  
Significantly enriched OTUs in R1 and R2 were defined similarly, except an increase 
in mean intensity.  Significantly distinct OTUs in R1 (ERY-H2O of 50ug/L) relative 
to R2 (ERY of 100μg/L) were defined as those present in R1 sample, achieving a 
probability values p<0.05 with Student’s t-test upon log2(concentration), and a 
difference in mean intensity compared to R2 of >400 units and >30%.  When 
summarizing PhyloChip results to subfamily, the taxon with a probe set producing the 
highest percent difference in mean intensity within the subfamily was used.   
 
5.4     Results  
5.4.1    NMDS analysis of bacterial population shifts 
Archaeal and bacterial 16S rRNA genes were amplified and analysed on PhyloChip 
microarray.  PhyloChip detected only two archaeal OTUs that belong to 
Euryarchaeota Phylum, indicating that archaea can be ignored in these three SBR 
systems.  Analysis of bacterial 16S rRNA genes by PhyloChip microarray and TRFLP 
suggested that ERY (100 µg/L in R2) and ERY-H2O (50 µg/L in R1) significantly 
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altered the bacterial community composition and structure (Fig.5.1).  Ordination of 
bacterial 16S rRNA gene composition revealed three distinct clusters of samples from 
R1, R2 and R3, respectively.  No any other physical or chemical factors were 
different between these groups except the presence/absence of ERY or ERY-H2O, 
indicating that bacteria were responding directly to the presence of ERY or ERY-H2O.   
 
Fig. 5.1 Microbial community analysis of R1 (ERY-H2O), R2 (ERY) and R3 (control) 
samples. Differences in composition of 16S rRNA gene sequences (a) measured by 
PhyloChip were analyzed using nonmentric multidimensional scaling (NMDS) 
ordination of Bray-Curtis distance (stress = 0.01 and 0, respectively). Communities of 




Continued Fig. 5.1 Microbial community analysis of R1 (ERY-H2O), R2 (ERY) and 
R3 (control) samples. Differences in composition of 16S rRNA gene sequences (b) 
based on terminal restriction fragments (T-RFs) were analyzed using nonmentric 
multidimensional scaling (NMDS) ordination of Bray-Curtis distance (stress = 0.01 
and 0, respectively). Communities of R1, R2 and R3 were clustered well apart from 
each other and can be significantly differentiated 
 
5.4.2    Bacterial richness identified by Phylochip analysis 
PhyloChip analysis revealed that 825, 699 and 920 distinct bacterial taxa belonging to 
37 phyla were present in R1 (ERY-H2O), R2 (ERY) and R3 (control) respectively, 
indicating that both ERY-H2O and ERY had a pronounced effect on bacterial 
community diversity, with taxonomic richness falling (Fig. 5.2 and 5.3).  .  
Taxonomic richness of R1 and R2 decreased significantly in bacteria classified as 
Gram-positive Actinobacteria (55, 28 and 62 taxa detected in R1, R2 and R3) and 
Gram-negative Proteobacteria (449, 354 and 509 taxa detected in R1, R2 and R3), 
which is consistent with that ERY has a broad antimicrobial spectrum of affecting 
both Gram-positive and Gram-negative bacteria, as well as suggests that ERY-H2O 
had the similar inhibitory spectrum as ERY (Amin et al., 2006).  Among 
Proteobacteria, only the richness of Betaproteobacteria decreased significantly in 
 119 
richness due to ERY-H2O, while the richness of Proteobacteria within all α, β, γ, δ, 
and ε subphyla decreased due to ERY, indicating that inhibitory spectrum of ERY-















































































Fig. 5.2 Bacterial richness detected in R1 (ERY-H2O), R2 (ERY) and R3 (control) 
samples.  Using PhyloChip analysis, (a) a total of 825, 699 and 920 OTUs in 37 
bacterial phyla were detected in samples R1, R2 and R3, respectively.  Taxonomic 
richness of bacteria in phylum Proteobacteria significantly decreased in R1 (50 µg/L 
of ERY-H2O) and R2 (100 µg/L of ERY) compared to R3 (control).  And richness of 
bacteria in phylum Actinobacteria also significantly decreased in R2 compared to R3. 
(b) Bacteria richness in all subphyla of Proteobacteria decreased in R1 and R2 












































Fig. 5.3 Phylum-level distribution of bacterial OTUs from R1 (ERY-H2O), R2 (ERY) 
and R3 (control) samples. Percent of taxonomic richness of Proteobacteria and 
Actinobacteria bacteria was significantly decreased in R2 (100 µg/L of ERY) 
compared to R3 (control)  
 
5.4.3    Most dynamic subfamilies identified by Phylochip analysis 
An OUT producing the highest mean intensity within the subfamily was used 
as the representative for summarizing PhyloChip results to subfamily.  Dynamic 
subfamilies were detected by confining the analysis to the 100 subfamilies exhibiting 
the greatest standard deviation between the SBRs sampled.  Hierarchical cluster 
analysis allowed detection of correlations between samples and also between 
subfamilies (Fig. 5.4).  Array analysis indicated that R2 (ERY) sample communities 
formed a separate cluster from those sampled from R1 (ERY-H2O) and R3 (control) 
with the latter two arising from a common node.  Overall, three groups of dynamic 
subfamilies were detected by cluster analysis (Fig. 5.4; see Table 5.1 of subfamilies).  
All the three cluster groups comprised subfamilies which were of lower abundance in 
R1 (ERY-H2O) and R2 (ERY) communities comparing with R3 (control), indicating 
that inhibition was the main effect of ERY and ERY-H2O on bacteria.   
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Cluster group 1 was a large cluster containing sequences from 57 bacterial 
subfamilies whose amplicons were of the lowest abundance in R1 (ERY-H2O) 
community relative to R2 (ERY) and R3 (control).  This group contained mostly 
Proteobacteria with some Acidobacteria, Actinobacteria, Bacteroidetes, and a few 
members of the Caldithrix, Chlorobi, Chloroflexi, Coprothermobacteria, 
Cyanobacteria, Firmicutes, Gemmatimonadetes, SPAM and TM7 phyla.  The 
Proteobacteria which responded in this manner were mostly orders within α 
(Acetobacterales, Azospirillales, Caulobacterales, Ellin314/wr0007, 
Ellin329/Riz1046, Rhodobacterales, Rickettsiales, Sphingomonadales), γ 
(Chromatiales, GAO cluster, Legionellales, Methylococcales, Oceanospirillales, 
Thiotrichales, Xanthomonadales) and δ (Desulfobacterales, Desulfovibrionales, 
Myxococcales, Syntrophobacterales) subphyla.  Two orders of Betaproteobacteria, 
Nitrosomonadales (capable of ammonium oxidizing) and Rhodocyclales (as nitrate 
reducer), and an Epsilonproteobacteria of the order Campylobacterales also responded 
in a similar way.   
Cluster group 2 consisted of Acidobacteria, Actinobacteria, Bacteroidetes, 
Chloroflexi, Firmicutes, OP 10, OP9/JS1, Proteobacteria and Synergistes sequences 
from 34 bacterial subfamilies, whose abundance was of the lowest in R2 (ERY) 
community.  This group contained the Acidobacteria within two classes, 
Acidobacteria-10 and Solibacteres.  Bacteria of the Actinobacteria were classified as 
families (Cellulomonadaceae, Corynebacteriaceae, Kineosporiaceae, Micrococcaceae, 
and Unclassified Actinomycetales) within the order of Actinomycetales, many of 
which are pathogens for human.  All three of the subfamilies from the Bacteroidetes 
were orders within Bacteroidales and Sphingobacteriales.  And the subfamilies from 
the Chloroflexi were unclassified.  In addition, members of the Gram-positive 
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Firmicutes were also detected within the families of Clostridiaceae, Lachnospiraceae 
and Peptostreptococcaceae, specifically the family of Clostridiaceae containing 
incredibly dangerous human pathogens Clostridium.  This cluster also contained 
Proteobacteria within orders of α (Bradyrhizobiales, Rhizobiales, Sphingomonadales), 
γ (Legionellales) and δ (AMD clone group, Desulfobacterales) subphyla. 
The final cluster group observed, group 3, comprised nine subfamilies which 
were of significantly lower abundance in R2 (ERY) bacteria than R1 (ERY-H2O).  
Two of the subfamilies were from the Actinobacteria within the families of 
Actinomycetaceae and Micromonosporaceae, with both representative clones 
(AJ428402.1 and AJ277568.1) being known to cause disease in humans and plants.  
One of the subfamily was from the class of Nitrospira, with members of Gram-negtive 
nitrite-oxidising organism.  The other nine members of cluster group 3 were 
Proteobacteria, with eight subfamilies from the orders of α (Azospirillales, 
Bradyrhizobiales, Rhizobiales) subphyla. 
In summary, analysis of 100 most dynamic subfamilies indicated that 
inhibition, the main effect of ERY-H2O and ERY on bacteria, mostly influenced on 
Actinobacteria and α, γ and δ subphyla of Proteobacteria, but less on β and ε 
Proteobacteria. In addition to Proteobacteria and Actinobacteria, Bacteroidetes and 
Chloroflexi were also affected by both ERY-H2O and ERY.  And Firmicutes, 




Fig. 5.4 Hierarchical cluster analysis showing the response of 100 most dynamic 
bacterial subfamilies (shown on y axis) exhibiting the highest standard deviation 
between R1 (ERY-H2O), R2 (ERY) and R3 (control) samples (shown on x axis). The 
color gradient from green, black to red represents gene intensity (after log 
transformation and median centered within the subfamily) from negative, zero to 
positive. Three main response groups were detected (Table 5.1) 
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Table 5.1 One hundred most dynamic bacterial subfamilies 
























































































































5.4.4    Variable subfamilies identified by Phylochip analysis 
Different from 100 most dynamic subfamilies, whose PhyloChip results were 
firstly summarized to subfamily followed by statistical analysis, significantly variable 
subfamilies were analyzed on all taxa and then the results were summarized to 
subfamily in the way that the taxon with a probe set producing the highest percent 
difference in mean intensity within the subfamily was used.   
Microarray analysis did not discover significantly enriched subfamily based on 
the filter conditions used in the statistical analysis.  Comparing communities of R1 
(ERY-H2O) and R2 (ERY) with R3, most of significantly inhibited subfamilies in R1 
(18 of 23 subfamilies) were also inhibited severely in R2 (Fig. 5.5, Table 5.2 and 5.3), 
indicating that ERY-H2O (50 µg/L in R1) had the similar inhibitory spectrum as ERY 
(100 µg/L in R2).  The subfamilies inhibited by both ERY-H2O and ERY were mostly 
classified as α, γ and δ subphyla of Proteobacteria and the phyla of Actinobacteria, 
with some from the Bacteroidetes, Chloroflexi.  The subfamilies from the 
Acidobacteria, Chlorobi, Firmicutes, Nitrospira and OP10 were only inhibited by 
ERY in R2.  One subfamily within the Verrucomicrobia was only inhibited 
significantly by ERY-H2O in R1, which was not included in the 100 most dynamic 
subfamilies.   
The subfamilies significantly distinct between R1 and R2 were mostly within 
the subfamilies inhibited by both ERY-H2O in R1 and ERY in R2, with relatively 
higher concentration of amplicons in R1 compared to R2, except the Verrucomicrobia 
with lower concentrations in R1 (Fig. 5.6 and Table 5.4).  The results of distinct 
subfamilies between R1 and R2 suggested that the inhibitory effects of ERY-H2O (50 
µg/L in R1) on bacteria was not as significant as ERY, although having the similar 
inhibitory spectrum.  
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Fig. 5.5 Bacterial subfamilies inhibited by (a) 50 µg/L of ERY-H2O in R1 and (b) 100 
µg/L of ERY in R2. Differences in estimated 16S rRNA gene concentration are 
shown as percent of R3 (control) concentration for a representative OTU in each of 
the subfamilies that were significantly inhibited in R1 (Table 5.2, 23 representative 
OTUs) or R2 (Table 5.3, 61 representative OTUs) samples 
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Table 5.2 Bacterial subfamilies significantly inhibited by 50 µg/L of ERY-H2O in R1 
 Phylum Class Order Family Representative sequence Concentration 
decreased (%) 
1 Actinobacteria Actinobacteria Actinomycetales Cellulomonadaceae Y18378.1  Beutenbergia 
cavernosa str. DSM 12333 
91  
2 Actinobacteria Actinobacteria Actinomycetales Corynebacteriaceae  87  
3 Actinobacteria Actinobacteria Actinomycetales Kineosporiaceae X77958.1  Kineococcus 
aurantiacus str. IFO 15268 
84  
4 Actinobacteria Actinobacteria Actinomycetales Kribbella AY253862.1  Kribbella solani 
str. DSA1 
62  
5 Actinobacteria Actinobacteria Actinomycetales Micrococcaceae AF134179.1  Arthrobacter 
psychrolactophilus 
85  
6 Actinobacteria Actinobacteria Actinomycetales Unclassified AJ626896.1  Jonesia 
quinghaiensis str. DSM 15701 
92  
7 Bacteroidetes Bacteroidetes Bacteroidales Prevotellaceae AB185583.1  rumen clone F24-
B03 
80  
8 Bacteroidetes Bacteroidetes Bacteroidales Unclassified AJ534685.1  ground water 
deep-well injection disposal 
site radioactive wastes Tomsk-
7 clone S15A-MN91 
85  




10 Bacteroidetes Sphingobacteria Sphingobacteriales Unclassified AJ007870.1  cytophagales 
clone LD1 
88  
11 Chloroflexi Anaerolineae Unclassified Unclassified AY218649.1  penguin 
droppings sediments clone 
87  
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 Phylum Class Order Family Representative sequence Concentration 
decreased (%) 
KD4-96 
12 Proteobacteria Alphaproteobacteria Bradyrhizobiales Bradyrhizobiaceae AB087719.1  
Rhodopseudomonas 
rhenobacensis str. Klemme Rb 
68  
13 Proteobacteria Alphaproteobacteria Bradyrhizobiales Unclassified AF288309.1  Bosea 
massiliensis str. 63287 
76  
14 Proteobacteria Alphaproteobacteria Rhizobiales Unclassified  85  
15 Proteobacteria Alphaproteobacteria Unclassified Unclassified D88520.1  Stappia aggregata 
str. IAM12614 
66  
16 Proteobacteria Betaproteobacteria Rhodocyclales Rhodocyclaceae X74913.1  Zoogloea ramigera 
str. ATCC 19544 (T) 
94  
17 Proteobacteria Deltaproteobacteria AMD clone group Unclassified AF523883.1  coal effluent 
wetland clone RCP185 
82  
18 Proteobacteria Deltaproteobacteria Desulfobacterales Desulfobulbaceae AF099059.1  Psychrophilic 
sulfate-reducing isolate str. 
LSv23 bacterium 
61  
19 Proteobacteria Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae AF228127.2  Desulfovibrio sp. 
str. Ac5.2 
87  
20 Proteobacteria Gammaproteobacteria Chromatiales Chromatiaceae AJ010297.2  Thiorhodovibrio 
sibirica 
76  
21 Proteobacteria Gammaproteobacteria Legionellales Legionellaceae CR628336.1  Legionella 
pneumophila str. Paris 
94  
22 Proteobacteria Gammaproteobacteria Methylococcales Methylococcaceae  74  
23 Verrucomicrobia Verrucomicrobiae Verrucomicrobiales Verrucomicrobia 
subdivision 3 
AF523995.1  coal effluent 




Table 5.3 Bacterial subfamilies significantly inhibited by 100 µg/L of ERY in R2 
 Phylum Class Order Family Representative sequence Concentration 
decreased (%) 
1 Acidobacteria Acidobacteria Acidobacteriales Acidobacteriaceae AY234728.1  Solibacter usitatus 
Ellin6076 
90  
2 Actinobacteria Actinobacteria Actinomycetales Actinomycetaceae AJ428402.1  Varibaculum 
cambriense str. CCUG 44998 
85  
3 Actinobacteria Actinobacteria Actinomycetales Cellulomonadaceae Y18378.1  Beutenbergia 
cavernosa str. DSM 12333 
93  
4 Actinobacteria Actinobacteria Actinomycetales Corynebacteriaceae X84446.1  Corynebacterium 
xerosis str. DSM 20743 
57  
5 Actinobacteria Actinobacteria Actinomycetales Kineosporiaceae X77958.1  Kineococcus 
aurantiacus str. IFO 15268 
89  
6 Actinobacteria Actinobacteria Actinomycetales Kribbella AY253862.1  Kribbella solani 
str. DSA1 
59  
7 Actinobacteria Actinobacteria Actinomycetales Micrococcaceae AF134179.1  Arthrobacter 
psychrolactophilus 
92  
8 Actinobacteria Actinobacteria Actinomycetales Micromonosporaceae AJ277568.1  Actinoplanes 
durhamensis str. IMSNU 
22124T 
86  
9 Actinobacteria Actinobacteria Actinomycetales Mycobacteriaceae X52925.1  Mycobacterium terrae 
str. ATCC 15755 
80  
10 Actinobacteria Actinobacteria Actinomycetales Propionibacteriaceae AJ315953.1  Propionibacterium 
propionicum str. DSM 43307T 
65  
11 Actinobacteria Actinobacteria Actinomycetales Sporichthyaceae AY250883.1  lichen-dominated 
Antarctic cryptoendolithic 
community clone FBP417 
79  
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 Phylum Class Order Family Representative sequence Concentration 
decreased (%) 
12 Actinobacteria Actinobacteria Actinomycetales Unclassified AJ626896.1  Jonesia 
quinghaiensis str. DSM 15701 
94  
13 Actinobacteria Actinobacteria Rubrobacterales Rubrobacteraceae  87  
14 Bacteroidetes Bacteroidetes Bacteroidales Prevotellaceae AB185583.1  rumen clone F24-
B03 
89  
15 Bacteroidetes Bacteroidetes Bacteroidales Rikenellaceae AJ534686.1  ground water deep-
well injection disposal site 
radioactive wastes Tomsk-7 
clone S15A-MN128 
85  
16 Bacteroidetes Bacteroidetes Bacteroidales Unclassified AJ534685.1  ground water deep-
well injection disposal site 
radioactive wastes Tomsk-7 
clone S15A-MN91 
85  
17 Bacteroidetes Sphingobacteria Sphingobacteriales Crenotrichaceae  87  
18 Bacteroidetes Sphingobacteria Sphingobacteriales Unclassified AJ007870.1  cytophagales clone 
LD1 
88  
19 Chlorobi Chlorobia Chlorobiales Chlorobiaceae Y08105.1  Chlorobium 
phaeovibrioides str. 2631 
88  
20 Chloroflexi Anaerolineae Unclassified Unclassified AY218649.1  penguin droppings 
sediments clone KD4-96 
90  
21 Chloroflexi Chloroflexi-3 Roseiflexales Unclassified AB079645.1  Green non-sulfur 
isolate str. B1-5 
97  
22 Chloroflexi Unclassified Unclassified Unclassified AF507693.1  forest soil clone 
S085 
96  
23 Firmicutes Clostridia Clostridiales Clostridiaceae  66  
24 Firmicutes Clostridia Clostridiales Unclassified  95  
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 Phylum Class Order Family Representative sequence Concentration 
decreased (%) 
25 Firmicutes gut clone group Unclassified Unclassified AB185532.1  rumen clone F23-
C12 
79  
26 Nitrospira Nitrospira Nitrospirales Nitrospiraceae AF033558.1  nitrifying sludge 
clone A-11 
92  
27 OP10 CH21 cluster Unclassified Unclassified AF368184.1  sludge clone 
SBRA136 
94  
28 OP10 Unclassified Unclassified Unclassified AF524022.1  forested wetland 
clone FW68 
87  
29 Proteobacteria Alphaproteobacteria Azospirillales Magnetospirillaceae AY171615.1  Dechlorospirillum 
sp. str. SN1 
94  
30 Proteobacteria Alphaproteobacteria Bradyrhizobiales Beijerinck/Rhodoplan 
/Methylocyst 
AB119196.1  Beijerinckia indica 99  
31 Proteobacteria Alphaproteobacteria Bradyrhizobiales Bradyrhizobiaceae AB099659.1  Oligotropha 
carboxidovorans str. S23 
97  
32 Proteobacteria Alphaproteobacteria Bradyrhizobiales Hyphomicrobiaceae Y14304.1  Hyphomicrobium 
aestuarii str. DSM 1564 
82  
33 Proteobacteria Alphaproteobacteria Bradyrhizobiales Unclassified AF288309.1  Bosea massiliensis 
str. 63287 
87  
34 Proteobacteria Alphaproteobacteria Caulobacterales Caulobacteraceae AB021414.1  Brevundimonas 
vesicularis str. IAM 12105T 
91  
35 Proteobacteria Alphaproteobacteria Consistiales Caedibacteraceae AJ428412.1  periodontal pocket 
clone 10B6 
75  
36 Proteobacteria Alphaproteobacteria Rhizobiales Bartonellaceae U87831.1  aortic heart valve 
patient with endocarditis clone 
v9 
89  
37 Proteobacteria Alphaproteobacteria Rhizobiales Beijerinck/Rhodoplan  92  
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 Phylum Class Order Family Representative sequence Concentration 
decreased (%) 
/Methylocyst 
38 Proteobacteria Alphaproteobacteria Rhizobiales Bradyrhizobiaceae  94  
39 Proteobacteria Alphaproteobacteria Rhizobiales Brucellaceae  84  
40 Proteobacteria Alphaproteobacteria Rhizobiales Hyphomicrobiaceae  92  
41 Proteobacteria Alphaproteobacteria Rhizobiales Phyllobacteriaceae U50164.1  Mesorhizobium loti 
str. R8CS USDA 3467 
85  
42 Proteobacteria Alphaproteobacteria Rhizobiales Rhizobiaceae AF025852.1  Rhizobium 
huautlense str. SO2 
83  
43 Proteobacteria Alphaproteobacteria Rhizobiales Unclassified  98  
44 Proteobacteria Alphaproteobacteria Rhizobiales Unclassified X74915.1  Shinella zoogloeoides 
str. ATCC 19623 
85  
45 Proteobacteria Alphaproteobacteria Rhodobacterales Hyphomonadaceae AJ227809.2  Maricaulis indicus 
str. MCS26 
82  
46 Proteobacteria Alphaproteobacteria Rhodobacterales Rhodobacteraceae AF234741.1  sludge clone A6 71  
47 Proteobacteria Alphaproteobacteria Rhodobacterales Unclassified AF502220.1 EBPR sludge lab 
scale clone HP1B78 
96  
48 Proteobacteria Alphaproteobacteria Unclassified Unclassified D88520.1  Stappia aggregata str. 
IAM12614 
88  
49 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae AF236009.1  isolate str. A1004 67  
50 Proteobacteria Deltaproteobacteria AMD clone group Unclassified AF523883.1  coal effluent 
wetland clone RCP185 
89  
51 Proteobacteria Deltaproteobacteria Desulfobacterales Desulfobacteraceae  81  
52 Proteobacteria Deltaproteobacteria Desulfobacterales Nitrospinaceae AJ296568.1  uranium mining 
mill tailing clone GR-296.II.52 
GR-296.I.52 
85  
53 Proteobacteria Deltaproteobacteria Desulfobacterales Unclassified AF420340.1  hydrothermal 88  
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 Phylum Class Order Family Representative sequence Concentration 
decreased (%) 
sediment clone AF420340 
54 Proteobacteria Deltaproteobacteria Myxococcales Polyangiaceae AJ518792.1  uranium mining 
waste pile clone JG37-AG-33 
proteobacterium 
68  
55 Proteobacteria Deltaproteobacteria Syntrophobacterales Syntrophobacteraceae AJ518800.1  uranium mining 
waste pile clone JG37-AG-128 
proteobacterium 
86  
56 Proteobacteria Deltaproteobacteria Unclassified Unclassified AY177804.1 Antarctic sediment 
clone LH5_30 
79  
57 Proteobacteria Gammaproteobacteria Legionellales Legionellaceae CR628336.1  Legionella 
pneumophila str. Paris 
95  
58 Proteobacteria Gammaproteobacteria Methylococcales Methylococcaceae  72  
59 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae AJ293826.1  Arctic seawater 
isolate str. R7366 
71  
60 Proteobacteria Unclassified Unclassified Unclassified  93  
61 Unclassified Unclassified Unclassified Unclassified  91  
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Percent difference in concentration
 
Fig. 5.6 Bacterial subfamilies differentiated between R1 (50 µg/L of ERY-H2O) and 
R2 (100 µg/L of ERY). Differences in estimated 16S rRNA gene concentration are 
shown as percent of R2 concentration for a representative OTU in each of the 
subfamilies that were inhibited less significantly in R1 than in R2 samples (Table 5.4) 
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Table 5.4 Bacterial subfamilies differentiated between R1 (50 µg/L of ERY-H2O) and R2 (100 µg/L of ERY) 
 Phylum Class Order Family Representative sequence Concentration 
difference (%) 
1 Actinobacteria Actinobacteria Actinomycetales Corynebacteriaceae X84446.1  Corynebacterium 
xerosis str. DSM 20743 
225  
2 Proteobacteria Alphaproteobacteria Bradyrhizobiales Beijerinck/Rhodoplan/
Methylocyst 
AB119196.1  Beijerinckia 
indica 
1897  
3 Proteobacteria Alphaproteobacteria Bradyrhizobiales Bradyrhizobiaceae AB099659.1  Oligotropha 
carboxidovorans str. S23 
2430  
4 Proteobacteria Alphaproteobacteria Bradyrhizobiales Unclassified AB033757.1  Blastochloris 
sulfoviridis str. GN1 
224  
5 Proteobacteria Alphaproteobacteria Rhizobiales Hyphomicrobiaceae  247  
6 Proteobacteria Alphaproteobacteria Rhizobiales Unclassified  505  
7 Proteobacteria Alphaproteobacteria Unclassified Unclassified D88520.1 Stappia aggregata 
str. IAM12614 
183  
8 Proteobacteria Gammaproteobacteria Pasteurellales Pasteurellaceae AF549390.1  Histophilus 
somni str. CCUG 12839 
221  
9 Proteobacteria Unclassified Unclassified Unclassified  303  
10 Verrucomicrobia Verrucomicrobiae Verrucomicrobiales Unclassified  -83  
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5.4.5    PCR-DGGE analysis of bacterial population shifts 
In order to determine which bacterial group or taxon particular bands could be 
ascribed, specific DGGE band fragments that became intensified in the sample of R1 
and R2 relative to R3 were further characterized by sequencing. In all, 8 different 
bands that became intensified in the sample of R1 (ERY-H2O) and R2 (ERY) relative 
to R3 (control) were excised from the gel for further sequence (Fig. 5.7).  The 
sequences obtained were compared with the NCBI database and phylogenetic tree 
was built, which were classified as the family of Rhodocyclaceae (capable of nitrate 
reduction), the genus of Nitrosomonas (able to oxidize ammonium) and the TM7 
candidate division (Fig. 5.8).  Bands 1–7 that intensified during exposure to ERY-
H2O belonged to the TM7 candidate division (band 5 and 6, 100% similarity) and the 
Gram-negative Betaproteobacteria within the families of Rhodocyclaceae (Band 1 and 
2, 97% and 99% similar to Zoogloea; Band 3, 95% similar to Thauera; Band 7, 88% 
similar to Azonexus) and Notrosomonadaceae (Band 4, 97% similar to Nitrosomonas).  
Band 2, 4, 5 and 6 were also intensified during exposure to ERY, but Band 1 and 3 
were not.  Another Band 8 (97% similar to Dechloromonas) intensified due to ERY 
also belonged to the family of Rhodocyclaceae.  These enriched bacteria are mostly 
related to bacterial biofilm or the so-called activated sludge floc, through which 
antibiotic stress was reduced (Anderson and O'Toole, 2008). 
We also found that one of the subfamily inhibited by ERY-H2O in R1 (Fig 
5.5a, and Table 5.2) was from the family Rhodocyclaceae, with the representative 
sequence of Zoogloea ramigera str. (ATCC 19544, X74913.1).  And another 
subfamily inhibited (Fig 5.4, and Table 5.1) was from the family of 
Notrosomonadaceae, with the representative clone of Nitrosomonas.  Accordingly, 
even bacteria from the same genus (e.g., Zoogloea and Nitrosomonas) may be 
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impacted by ERY-H2O (or ERY) in completely different ways, either inhibition or 
selection, which may depend on the absence/presence of antibiotic resistance 
genotypes or phonotypes. 
 
Fig. 5.7 DGGE profiles of microbes in R1 (ERY-H2O), R2 (ERY) and R3 (control). 
Sequence blast results of DGGE bands intensified in R1 and R2 relative to R3 are: 
Band 1 and 2 Uncultured Zoogloea, Band 3 Uncultured Thauera, Band 4 Uncultured 
Nitrosomonas, Band 5 and 6 Uncultured TM7 bacterium, Band 7 Uncultured 







Fig. 5.8 Phylogenetic tree of the 16S rRNA gene sequences from DGGE band 
fragments that became intensified in the sample of R1 (ERY-H2O), and R2 (ERY) 
relative to R3 (control) were constructed with the neighbor-jointing method ordination 
of p-distance by software MEGA 4.  GeneBank accession numbers of sequences are 
given in parenthesis. And genetic similarity is above 95% between the gene detected 
in this study and each corresponding sequence, except that uncultured Azonexus 
detected in DGGE band 7 is 88% similar to its corresponding sequences  
 
5.5     Discussion  
Investigations on the influence of sub-inhibitory concentrations of antibiotics 
and their derivatives on the microbial communities of WWTPs are important due to 
the intimate contact of wastewater and sewage sludge with people via wastewater 
reclamation processes and fertilizer application, respectively (Ding and He, 2010; Le-
Minh et al., 2010).  On the other hand, the investigations are increasingly difficult 
since the influence is less pronounced due to the low concentrations of these 
compounds in WWTPs.  In order to make influence of ERY (100 µg/L) and ERY-
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H2O (50 µg/L) detectable in SBRs, this study attained a good baseline from negative 
control SBR that was antibiotics-uncontaminated, explored SBRs that excluded 
external input of antibiotic resistant bacteria and resistance genes in case of masking 
the effects of antibiotics themselves, and treated microbial consortia of SBRs with 
ERY or ERY-H2O for long time (over one year).  Moreover, various uncultured-
methods, especially high-density microarray (PhyloChip), were used in this study to 
give a comprehensive picture of the microbial communities.  Compared to culture-
based methods, the microarray technique has often been proved to be potent to profile 
microbial diversities in higher richness (DeSantis et al., 2007; DeSantis et al., 2005; 
Hazen et al., 2010), and we found this was also true in this study. 
As expected, all these efforts worked together to first time display the 
pronounced influence of low concentrations of ERY and ERY-H2O on the microbial 
communities in SBRs.  Both ERY and ERY-H2O at low concentrations (µg/L level) 
were found to lead to the microbial community shift as revealed by the NMDS result 
that the microbial communities formed two distinct clusters responding to the 
presence of ERY and ERY-H2O (Fig.5.1).  And the PhyloChip analysis showed that 
the two microbial communities shifted at a similar trend that taxonomic richness was 
lower and abundance was decreased in the similar inhibitory spectrum of Gram-
negative Proteobacteria and Gram-positive Actinobacteria, whereas ERY-H2O posed 
less considerably inhibitory effects on microbes than ERY did (Fig. 5.2–5.6 and table 
5.1–5.4).  The findings recall the concern on the unfavorable influence of antibiotic 
derivatives in the environment, although the derivatives were usually reported to 
possess negligible antibacterial activity due to the destruction or modification of 
antibiotic functional groups (Schlunzen et al., 2001; Wright, 2005).  The similarly but 
less significantly inhibitory effects of antibiotic derivatives compared to their parent 
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antibiotics may act as vaccines for bacteria to build resistance more easily to the 
parent drugs, which may be more harmful to the human health than antibiotics 
themselves present in the environment.  This has been confirmed in the previous 
studies that ERY-H2O is able to induce microbial resistance to ERY (Fan et al., 2009; 
Majer, 1981).  All these findings highlight that antibiotic derivatives (e.g., ERY-H2O) 
may have equally vital inhibitory effects on natural microorganisms as their original 
antibiotics.  Further study is needed to focus on both antibiotics and their derivatives 
in the environment. 
Although inhibited microbes were discovered in the microbial communities 
exposed to external pressure (ERY and ERY-H2O), there is the lack of information on 
the bacteria selected by ERY and ERY-H2O.  Here, PhyloChip microarray that can 
only give microbial community information in the subfamily level may lose the 
information of selected bacteria in low-level taxonomic rank (e.g., genus).  Therefore, 
DGGE that can differentiate microbes with only one base variation was used in this 
study to target intensified bacteria in the community, rather than to target inhibited 
bacteria since DGGE is weak in targeting less dominant component bacteria.  The 
results of DGGE, as expected, provide a picture that the presence of ERY and ERY-
H2O can lead similar enriched-bacteria spectrum, with common enriched-bacteria 
from the phylum of TM7 candidate division and the subphylum of Betaproteobacteria 
within the families of Rhodocyclaceae (Zoogloea, Azonexus) and Notrosomonadaceae 
(Nitrosomonas), and with ERY-enriched Dechloromonas and ERY-H2O-enriched 
Thauera that both belonged to the family of Rhodocyclaceae (Fig. 5.7 and 5.8).  
Zoogloea is vital in maintaining activated sludge floc through excretion of EPS.  
Bacteria in floc or biofilm can increase antibiotic resistance 10 to 1,000 folds 
comparing to their planktonic formation via various mechanisms, one of which is 
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formation of microenvironment within biofilm that is lack of nutrient and oxygen and 
results in higher resistant bacteria with limited growth but enhanced anaerobic 
elimination of toxic intermediates (Anderson and O'Toole, 2008).  For example, 
antibiotics triggered Pseudomonas aeruginosa biofilm can carry out anaerobic 
respiration of NO3– and NO2– into N2 to prevent accumulation of nitric oxide through 
genes nar , nir , nor , and nos that are regulated by quorum sensing gene rhlR (Hassett 
et al., 2002).  In this study, those enriched bacteria due to presence of ERY and ERY-
H2O may process enhanced ability to remove nitrate and ammonium similarly as 
shown in the above study, since most members of the genera Azoarcus, Thauera and 
Dechloromonas are reported to proceed the anaerobic reduction of nitrate coupled 
with degradation of anthropogenic compounds, and Nitrosomonas are well-known 
ammonium oxidizer (Loy et al., 2005).  Further study is needed to clarify the genetic 
regulation of these biofilm antibiotic resistance mechanisms.   
Noteworthy, even bacteria belonging to same genus (e.g., Zoogloea and 
Nitrosomonas) were affected differently by spiked ERY and ERY-H2O, either 
inhibition or enrichment.  The contrary effects of ERY and ERY-H2O may be offset 
in the higher subfamily level targeted by the PhyloChip, which may explain why the 
PhyloChip analysis can not discover selected bacteria.  The finding also indicate that 
functionally redundant groups in the complex microbial communities are important to 
sustain system stable under the selection of antibiotics.  This is consistant with the 
findings in the chapter 3 that nitrifying bacteria (AOMs and NOBs) in all three SBRs 
had the same nitrification performance (Fig. 3.2, Fig. 3.3 and Fig. 3.4) although their 
diversity and total intensity were lower in R1 and R2 compared to R3, because the 
antibiotics-selected nitrifying bacteria may have a higher specific nitrification 
capacity (Table 3.1 and Fig. 3.6).  In full-scale WWTPs with more complex microbial 
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communities, the combined effects of multiple antibiotics and their derivatives are 
expected different from single antibiotic influence applied on simple lab-scale SBR 
microbes (Ding and He, 2010).  Future work is needed to study the mutiplex antibiotic 
influence on the microbial communities of WWTPs. 
    
5.6     Conclusions  
In summary, exposure to µg/L levels of ERY and ERY-H2O significantly 
shifted microbial communities at similar ways that the diversity and abundance of 
bacteria decreased, especially on Gram-negative α-, γ- and δ- Proteobacteria and 
Gram-positive Actinobacteria, but that biofilm antibiotic resistant β-proteobacteria 
within the families of Rhodocyclaceae and Notrosomonadaceae were selected.  This 
study will provide important information to substantiate the influence of antibiotics 
and their derivatives at sub-inhibitory concentrations on the inhibition of sensitive 



















Chapter 6     
Conclusions and recommendations 
 151 
6.1     Conclusions  
The lack of knowledge on the roles of antibiotics and antibiotic resistance 
genes in the environment has hampered efforts to prevent and control the proliferation 
of antibiotic resistance.  As such, there is a need to study antibiotic influence on 
WWTPs, which are the main collection pools of anthropogenic discharges of 
antibiotics and antibiotic resistance.  To address this need, the influence of antibiotics 
ERY and its derivative ERY-H2O at µg/L levels was studied on the micro-ecosystem 
of lab-scale SBRs, in terms of ecological function disturbance, resistance selection 
and phylogenetic structure alteration.  The results revealed that at low concentrations, 
both ERY and ERY-H2O shared similar spectrums of sensitive bacteria and resistant 
bacteria.  The enrichment of the resistant bacteria include those are capable of 
esterifying ERY via esterase ereA gene, as well as those are capable of forming 
biofilm and consequently enhanced the elimination of toxic nitrogenous substances. 
All these may offset the inhibitory effects of ERY and ERY-H2O on the SBR 
microorganisms.  The followings are important conclusions attained in this study. 
1. This doctoral study has demonstrated that ERY-H2O (50 µg/L) and ERY (100 
µg/L) revealed no significant impact on the carbon and nutrients (N and P) 
removal efficiency of SBRs in treating the synthetic wastewater.   
2. However, both ERY-H2O (50 µg/L) and ERY (100 µg/L)  can cause the 
composition changes of the microbial communities associated with the N and 
P removal in the reactors, leading to the selection of the microorganisms more 
resistant to ERY and ERY-H2O.   
3. This study suggests that the influence of ERY and ERY-H2O at the µg/L 
levels is more likely to induce a pool of ERY resistant bacteria than to inhibit 
the treatment of systems (e.g., WWTPs).  
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4. This study also demonstrated that both ERY-H2O (50 µg/L) and ERY (100 
µg/L) can encourage the development of ERY esterase gene ereA in the 
conditions of free of continuous input of resistant bacteria and genes.   
5. ERY acclimated microbes can esterify ERY via ereA gene, whereas ERY-
H2O acclimated ones cannot do as ERY acclimated ones, which may be due to 
the less proliferated ereA gene.  Esterification of ERY required the presence 
of exogenous carbon source (e.g., glucose) and nutrients (e.g., nitrogen, 
phosphorus) for assimilation, but overdosed ammonium–N (>40 mg/L) 
inhibited degradation of ERY.   
6. Zoogloea, a type of biofilm-forming bacteria, became predominant in the ERY 
esterification consortia, suggesting that the input of ERY could induce biofilm 
resistance to antibiotics. 
7. Low concentrations of ERY and ERY-H2O in the environment can result in 
the proliferation of antibiotic resistance genes.  This study also provides 
important information to substantiate the correlation between the proliferation 
of antibiotic resistance and the antibiotics at sub-inhibitory concentrations. 
8. Finally, this study demonstrated that both ERY and ERY-H2O significantly 
shifted the microbial communities in similar ways.   
9. It was found that Gram-negative α-, γ- and δ-Proteobacteria and the Gram-
positive Actinobacteria were inhibited by both ERY and ERY-H2O, but in 
different extent that ERY-H2O posed less considerably inhibitory effects on 
microbes than ERY did. 
10. The β-proteobacteria within the families of Rhodocyclaceae (Azoarcus, 
Thauera, Dechloromonas and zoogloea) and Notrosomonadaceae 
(Nitrosomonas) were enriched by both ERY and ERY-H2O.  The enrichment 
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resulted in the increase of antibiotic resistance due to the formation of biofilm 
by the zoogloea, the enhancement of ammonium oxidization by the 
Nitrosomonas, and the improvement of nitrate reduction by the Azoarcus, 
Dechloromonas and Thauera. 
11. This study offers insights on the influence of sub-inhibitory concentrations of 
antibiotics and their derivatives on antibiotic sensitive and resistant bacteria.  
In summary, it was found that even low concentrations of antibiotics and their 
derivatives were able to induce resistance genes, form antibiotic resistant biofilm and 
select resistant bacteria.  
 
6.2     Recommendations 
In the course of studying the influence of antibiotics ERY and its derivative 
ERY-H2O on the microbial communities of lab-scale SBRs, there remain many 
important questions that require future research. 
In chapter 3, the PhyloChip results on PAOs and GAOs were insufficient to 
explain the slightly improved phosphorus removal in ERY-H2O-spiked R1 (than 
ERY-spiked R2 and control reactor R3). This is mainly because PAOs and GAOs 
include largely uncertain phylotypes that are not targeted by the PhyloChip used in 
this study (Seviour et al., 2003).  Therefore, more information is needed in the future 
study.  The new generation PhyloChip G3 that targets more PAOs and GAOs can be 
used to identify the bacteria related phosphorus removal in WWTPs.  
Higher concentrations of ammonium (NH4+–N>40 mg/L) were found to 
inhibit ERY biodegradation for more than 30% (chapter 4).  The even higher 
concentrations of ammonium in pharmaceutical wastewater will definitely make ERY 
biodegradation more difficult to occur.  The untreated ERY, in turn, will inhibit 
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ammonium oxidization.  Awareness is needed to optimize WWTPs to cope with this 
problem.  
The intermediates of antibiotics may induce microbial resistance to the parent 
drugs (Fan et al., 2009; Majer, 1981).  In chapter 4, study on ERY-H2O confirmed the 
above resistance development principle on resistance gene ereA.  Future study may 
need to find out whether the degradation products of other antibiotics can still induce 
resistance to their parent drugs as ERY-H2O does to ERY (Fan et al., 2009; Majer, 
1981).   
In chapter 5, ERY and ERY-H2O at low concentrations (µg/L level) can shift 
microbial communities at the similar trend, and they both can induce biofilm 
antibiotic resistance (Fajardo and Martinez, 2008).  All these findings indicate that 
antibiotic derivatives (e.g., ERY-H2O) may have the equally vital effects on 
microorganisms as their original antibiotics.  Future study may need to focus on both 
antibiotics and their derivatives in the environment, to clarify their roles in the 
development of antibiotic resistant bacteria, and to identify gene-based biofilm 
antibiotic resistance (e.g., genetic regulators involved in biofilm formation).   
The presence of antibiotics and their derivatives in the intestine of animals and 
human beings may also induce the formation of biofilm in such environments as those 
do in WWTPs.  Inside the intestinal biofilm, the accumulated toxic compound NO2- 
may combine with a second amine to form nitrosamine, which is a carcinogen and 
may be harmful to the animals and human beings (Huang et al., 1996).  Therefore, 
concerns will be raised on the unfavorable influence of antibiotics applied in the 
disease treatment and further study should be carried out to assess the impacts of 
antibiotics on the treatment of cancer patients. 
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Noteworthy, in chapter 5, even bacteria belonging to same genus (e.g., 
Zoogloea) were affected differently by spiked ERY and ERY-H2O, either inhibited or 
enriched.  This indicates that functionally redundant groups that are present in the 
complex microbial communities are important to sustain the stability of micro-
systems under the selection pressure of antibiotics.  In addition, WWTPs receive 
multiple antibiotics and their derivatives, and their combined effects are expected to 
be different from single antibiotic influence applied on microbes (Ding and He, 2010).  
Future work should focus more on the influence of mutiple antibiotics on complex 
microbial communities of real WWTPs than on relative simple lab-scale SBR fed 
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